<SEC-DOCUMENT>0001213900-25-102562.txt : 20251027
<SEC-HEADER>0001213900-25-102562.hdr.sgml : 20251027
<ACCEPTANCE-DATETIME>20251027160147
ACCESSION NUMBER:		0001213900-25-102562
CONFORMED SUBMISSION TYPE:	F-3
PUBLIC DOCUMENT COUNT:		18
FILED AS OF DATE:		20251027
DATE AS OF CHANGE:		20251027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wearable Devices Ltd.
		CENTRAL INDEX KEY:			0001887673
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		ORGANIZATION NAME:           	06 Technology
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-291100
		FILM NUMBER:		251419859

	BUSINESS ADDRESS:	
		STREET 1:		5 HA-TNUFA ST.
		CITY:			YOKNE'AM ILLIT
		STATE:			L3
		ZIP:			2066736
		BUSINESS PHONE:		97246185670

	MAIL ADDRESS:	
		STREET 1:		5 HA-TNUFA ST.
		CITY:			YOKNE'AM ILLIT
		STATE:			L3
		ZIP:			2066736
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-3
<SEQUENCE>1
<FILENAME>ea0262558-f3_wearable.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>As filed with the Securities and Exchange Commission on October 27, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM F-3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Wearable
Devices LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Not Applicable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of Registrant&rsquo;s Name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>State of Israel</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not Applicable</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of<BR>
incorporation or organization)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer<BR>
Identification No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5 Ha-Tnufa St. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Yokne&rsquo;am Illit, 2066736 Israel</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel: +972.4.6185670 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address and telephone number of Registrant&rsquo;s
principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Mudra Wearable, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>24A Trolley Square #2203</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Wilmington, DE 19806 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, and telephone number of agent for
service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Copies to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Oded Har-Even, Esq.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Howard E. Berkenblit, Esq.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sullivan &amp; Worcester LLP</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1251 Avenue of the Americas</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, NY 10020</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel: (212) 660-3000</B></P></TD>
    <TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 49%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Reut Alfiah, Adv.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Gal Cohen, Adv.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sullivan &amp; Worcester Tel Aviv (Har-Even
    &amp; Co.)</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>28 HaArba&rsquo;a St. HaArba&rsquo;a Towers</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>North Tower, 35th floor</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel Aviv, Israel 6473925</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel: +972 74-758-0480</B></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approximate date of commencement of proposed sale
to the public: From time to time after the effective date of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the only securities being registered on this
Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.
&#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a registration statement pursuant
to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment to
a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities
pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company &#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards&dagger; provided pursuant to Section 7(a)(2)(B) of the Securities
Act. &#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The term &ldquo;new or revised financial accounting standard&rdquo; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Registrant hereby amends this Registration
Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which
specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933 or until this Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting
pursuant to said Section 8(a), may determine.</B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>The information in
this prospectus is not complete and may be changed. The selling shareholder identified herein may not sell these securities until the
registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to
sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="color: Red"><B>PRELIMINARY
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="color: Red"><B>SUBJECT
TO COMPLETION, DATED OCTOBER 27, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>WEARABLE DEVICES LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Up to 3,322,000 Ordinary
Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Offered by the Selling
Shareholder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus relates to
the&nbsp;resale, from time to time, by the selling shareholder named herein, or the Selling Shareholder, or its pledgees, donees, transferees,
or other successors in interest, of up to 3,322,000 of our ordinary shares, no par value per share, or Ordinary Shares, that are issuable
upon exercise of&nbsp;3,322,000 warrants, or the New Warrants, held by the Selling Shareholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The New Warrants held by the
Selling Shareholder were sold to it by our company in a private placement that was completed on August 7, 2025 pursuant to that certain
inducement letter, dated as of August 6, 2025, or the Inducement Agreement, by and between our company and the Selling Shareholder. Pursuant
to that private placement, and following the approval of our shareholders on October 24, 2025, we issued to the Selling Shareholder an
aggregate of 3,322,000 New Warrants to purchase up to 3,322,000 Ordinary Shares.&nbsp;The New Warrants have an exercise price of $1.71
per share, were immediately exercisable upon issuance and will expire five years from issuance. The private placement was effected pursuant
to the exemptions provided in Section 4(a)(2) under the Securities Act of 1933, as amended, or the Securities Act, and Rule 506(b) of
Regulation D promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholder may
sell the 3,322,000 Ordinary Shares underlying the New Warrants held by it in one or more offerings under this prospectus, for its own
account. We will not receive any of the proceeds from the sale of Ordinary Shares by the Selling Shareholder. We will, however, receive
up to an aggregate of approximately $5.7 million in cash from the exercise of the&nbsp;New Warrants, assuming the exercise in full for
cash of all the New Warrants.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholder may
offer and sell any of the Ordinary Shares offered hereby from time to time at fixed prices, at market prices or at negotiated prices,
and may engage a broker, dealer or underwriter to sell the securities. In connection with any sales of Ordinary Shares offered hereunder,
the Selling Shareholder, any underwriters, agents, brokers or dealers participating in such sales may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the&nbsp;Securities Act. For additional information on the possible methods of sale that may be used by the Selling
Shareholder, you should refer to the section titled &ldquo;<I>Plan of Distribution</I>&rdquo; elsewhere in this prospectus. We do not
know when or in what amounts the Selling Shareholder may offer the Ordinary Shares for sale. The Selling Shareholder may sell any, all
or none of the shares offered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus,
our Ordinary Shares are listed and trade on the Nasdaq Capital Market under the symbol &ldquo;WLDS&rdquo;. The last reported sale price
of our Ordinary Shares on October 24, 2025 was $2.96 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Investing
in our Ordinary Shares is highly speculative and involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page 3
</B></FONT>&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif"><B>of this prospectus for a discussion of information that should
be considered in connection with an investment in our Ordinary Shares, as well as the risks described under the heading &ldquo;Item 3
Key Information &ndash; D. Risk Factors&rdquo; in our Annual Report on Form 20-F for the year ended December 31, 2024, or the 2024 Annual
Report, which we filed with the Securities and Exchange Commission on March 20, 2025, and in other documents incorporated by reference
into this prospectus<I>.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission, or the SEC, the Israel Securities Authority nor any state or other securities commission has approved or disapproved
of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">The date of this prospectus
is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>TABLE
OF CONTENTS</B>&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_001">OUR COMPANY</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 9%; text-align: center">1</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_002">ABOUT THIS OFFERING</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">2</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_003">RISK FACTORS</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">3</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_004">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">7</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_005">USE OF PROCEEDS</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">9</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_006">CAPITALIZATION</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">10</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_007">SELLING SHAREHOLDER</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">11</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_008">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">13</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_009">LEGAL MATTERS</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">15</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_010">EXPERTS</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">15</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_011">EXPENSES</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">15</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_012">ENFORCEABILITY OF CIVIL LIABILITIES</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">16</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_013">WHERE YOU CAN FIND ADDITIONAL INFORMATION</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">17</TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_014">INFORMATION INCORPORATED BY REFERENCE</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">18</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As
permitted under the rules of the U.S. Securities and Exchange Commission, or the SEC, this prospectus incorporates important information
about us that is contained in documents that we have previously filed with the SEC but that are not included in or delivered with this
prospectus. You may obtain copies of these documents, without charge, from the website maintained by the SEC at www.sec.gov, as well as
other sources. You may also obtain copies of the incorporated documents, without charge, upon written or oral request to Wearable Devices
Ltd., 5 Ha-Tnufa St., Yokne&rsquo;am Illit, 2066736, Israel, Attention: Chief Financial Officer. The telephone number of our registered
office is Telephone+972.4.6185670. See &ldquo;Where You Can Find Additional Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">You
should rely only on information contained in and incorporated by reference into this prospectus. We have not, and the Selling Shareholder
has not, authorized anyone to give any information or to make any representations other than those contained in this prospectus. We take
no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus
is not an offer to sell, and it is not soliciting an offer to buy, (1) any securities other than our Ordinary Shares or (2) our Ordinary
Shares in any circumstances in which such an offer or solicitation is unlawful. The information contained in this prospectus may change
after the date of this prospectus. Do not assume after the date of this prospectus that the information contained in this prospectus is
still correct. Information contained on our website, www.wearabledevices.co.il, does not constitute part of this prospectus.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
this prospectus, &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; the &ldquo;Company&rdquo; and &ldquo;Wearable Devices&rdquo; refer
to Wearable Devices Ltd. &ldquo;Mudra&rdquo; is a registered trademark of Wearable Devices Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All historical quantities
of Ordinary Shares and per share data presented herein give retroactive effect to our 1-for-4 reverse share split effected prior to the
start of trading on Nasdaq on March 17, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">All
trademarks or trade names referred to in this prospectus are the property of their respective owners. Solely for convenience, the trademarks
and trade names in this prospectus are referred to without the &reg; and &trade; symbols, but such references should not be construed
as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do
not intend the use or display of other companies&rsquo; trademarks and trade names to imply a relationship with, or endorsement or sponsorship
of us by, any other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
prospectus includes or incorporates by reference statistical, market and industry data and forecasts which we obtained from publicly available
information and independent industry publications and reports that we believe to be reliable sources. These publicly available industry
publications and reports generally state that they obtain their information from sources that they believe to be reliable, but they do
not guarantee the accuracy or completeness of the information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For investors outside of the
United States: Neither we nor the Selling Shareholder have done anything that would permit this offering or possession or distribution
of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required to
inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5.4pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>OUR COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Overview</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a growth company developing
a non-invasive neural input interface in the form of a wearable wristband for controlling digital devices using subtle finger gestures
and hand movements. Since our technology was introduced to the market in 2014, we have been working with both B2B and B2C customers as
part of our push-pull strategy. We are now in the transition phase from research and development to commercialization of our technology
into B2B products. At the same time, starting in December 2023, we have commenced shipment of the &ldquo;Mudra Band&rdquo;, our first
B2C consumer product, and aftermarket accessory band for Apple Watch that enables gesture control across Apple ecosystem devices such
as iPhone, Mac computer, Apple TV, and iPad, inter alia. In September 2024, we launched the Mudra Link, a universal gesture control wearable
wristband. The Mudra Link was opened for pre-orders in September 2024 and we started shipping to customers in the first quarter of 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our company&rsquo;s vision
is to create a world in which the user&rsquo;s hand becomes a universal input device for touchlessly interacting with technology. We believe
that our technology is setting the standard input interface for the Metaverse. We intend to transform interaction and control of digital
devices to be as natural and intuitive as real-life experiences. We imagine a future in which humans can share skills, thoughts, emotions,
and movements with each other and with computers, using wearable interfaces and devices. We believe that neural-based interfaces will
become as ubiquitous to interact with wearable computing and digital devices in the near future as the touchscreen is a universal input
method for smartphones.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Combining our own proprietary
sensors and AI algorithms into a stylish wristband, our Mudra platform enables users to control digital devices through subtle finger
movements and hand gestures, without physical touch or contact. These digital devices include consumer electronics, smart watches, smartphones,
augmented reality, or AR, glasses, virtual reality, or VR, headsets, televisions, personal computers and laptop computers, drones, robots,
etc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Mudra Development Kit
(formerly Mudra Inspire), our B2B development kit product, started selling to B2B customers in 2018 as the first point of business engagement
and contributed to our early-stage revenues. In 2024 and 2023, we had revenues of $522 thousand and $82 thousand, respectively, and comprehensive
and net loss of $7.9 million and $7.8 million, respectively. For the six months ended June 30, 2025 and June 30, 2024, we had revenues
of $294 thousand and $394 thousand, respectively, and comprehensive and net loss of $3.7 million and $4.2 million, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Over 100 companies have purchased
our Mudra Development Kit (formerly Mudra Inspire), 30 of which are multinational technology companies. These companies are exploring
various input and control use-cases for their products, ranging over multiple countries and industry sectors, including consumer electronics
manufacturers, consumer electronics brands, electronic components manufacturers, IT services and software development companies, industrial
companies, and utility providers. Our objective with these companies is to commercialize the Mudra technology by licensing it for integration
in the hardware and software of these companies&rsquo; products and services. We estimate that there will be a three-to-five-year period
from the time we are first introduced to a customer to signing a licensing agreement. As of October 24, 2025, we have not signed a license
agreement with any of these companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to consumer electronics,
we have recently expanded our brand to include neurotech and brain-computer interface sensors, with additional verticals that include
Industry 4.0 &ndash; a new phase in the Industrial Revolution that focuses on interconnectivity, automation, machine learning, and real-time
data, digital health, sport analytics, and more.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The core of our platform is
Mudra, which means &ldquo;gesture&rdquo; in Sanskrit. Mudra, our surface nerve conductance, or SNC, technology and wristband tracks neural
signals on the user&rsquo;s wrist skin surface, which our algorithms decipher to predict as gestures made by finger and hand movements.
The interface binds each gesture with a specific digital function, allowing users to input commands without physical touch or contact.
Mudra gestures are natural to perform, and gestures can be tailored per a user&rsquo;s intent, desired function, and the controlled digital
device. Mudra can detect multiple gesture types, including hand movements, finger movements, and fingertip pressure gradations. In addition
to the control use-case, our Mudra technology and SNC sensor can be utilized in multiple monitoring use-cases where we can monitor neural
and hand movements for digital health purposes, sport analytics performance, and Industry 4.0 solutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>August 2025 Warrant Inducement Transaction
and Private Placement of Warrants</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 6, 2025, we entered
into the Inducement Agreement with the Selling Shareholder with respect to outstanding warrants to purchase up to an aggregate of 1,661,000
of our Ordinary Shares. Pursuant to the Inducement Agreement, the Selling Shareholder agreed to exercise for cash warrants to purchase
up to 1,661,000 Ordinary Shares, originally issued on April 30, 2025, or the &ldquo;Existing Warrants, at an exercise price of $1.45 per
share. In consideration for the immediate exercise of the Existing Warrants, we agreed to issue to the Selling Shareholder New Warrants
to purchase up to an aggregate of 3,322,000 Ordinary Shares at an exercise price of $1.71 per share. The issuance of the New Warrants
was subject to approval by our shareholders, <FONT>which was obtained on October 24, 2025</FONT>. The
New Warrants are exercisable immediately upon issuance and expire five years from the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The exercise of the Existing
Warrants resulted in gross proceeds to the Company of approximately $2.4 million. The Company intends to use the net proceeds from the
exercise of the Existing Warrants for working capital and general corporate purposes.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 5.4pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>ABOUT THIS OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares outstanding prior to this offering:</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 71%">5,889,873 Ordinary Shares.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares offered by the Selling Shareholder:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to 3,322,000 Ordinary Shares consisting of 3,322,000 Ordinary Shares issuable upon the exercise of the New Warrants.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares to be outstanding after this offering<SUP>(1)</SUP>:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,211,873 Ordinary Shares, assuming the exercise in full of all of the New Warrants for cash and without adjustment.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Selling Shareholder will receive all of the proceeds from the sale of any Ordinary Shares sold by it pursuant to this prospectus. We will not receive any proceeds from the sale of the Ordinary Shares by the Selling Shareholder (although we may receive proceeds from any exercise of the New Warrants, to the extent such New Warrants are exercised by the Selling Shareholder for cash). See &ldquo;<I>Use of Proceeds</I>&rdquo; in this prospectus.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing in our securities is highly speculative and involves substantial risk.</B>&nbsp;You should carefully consider all the information in this prospectus prior to investing in our securities. In particular, we urge you to consider carefully the factors set forth in the section of this prospectus entitled &ldquo;Risk Factors&rdquo; beginning on page 3, including </FONT><FONT STYLE="font-size: 10pt">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">the risks described under the heading &ldquo;Item 3 Key Information - D. Risk Factors&rdquo; in the 2024 Annual Report.</FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Ordinary Shares are listed for trading on the Nasdaq Capital Market under the symbol &ldquo;WLDS&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.75pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of Ordinary Shares to be outstanding immediately after this offering is based on 5,889,873 Ordinary Shares outstanding as of October 24, 2025, and excludes, as of such date:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,222 Ordinary Shares issuable upon the exercise of outstanding options allocated or granted to directors, employees and consultants under our 2015 Share Option Plan, or the 2015 Plan, at a weighted average exercise price of $31.62 per Ordinary Share, of which 17,326 were vested as of October 24, 2025; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">277 Ordinary Shares issuable upon the exercise of warrants issued to a consultant, at an exercise price of $180.00 per Ordinary Share, and an additional 295 Ordinary Shares issuable upon the exercise of warrants issued to an advisor, at an exercise price of $338.40 per Ordinary Share; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,976 Ordinary Shares reserved for future issuance under the 2015 Plan;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,589 Ordinary Shares issuable upon the exercise of 98,589 IPO Warrants, at an exercise price of $160.00 per share, or the IPO Warrants, and warrants to purchase up to 2,344 Ordinary Shares, issued to the underwriter in our initial public offering, or IPO, at an exercise price of $424.80 per share, or the Underwriter&rsquo;s Warrants; &nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 Ordinary Shares reserved for issuance under the Standby Equity Purchase Agreement, dated June 6, 2024, between the Company and YA II PN, LTD., or the SEPA;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,500 Ordinary Shares reserved for future issuance under our 2024 Employee Stock Purchase Plan, or the 2024 Purchase Plan; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">157,627 Ordinary Shares reserved for future issuance under our 2024 Global Equity Incentive Plan,&nbsp;or the 2024 Plan;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">554,888 Ordinary Shares issuable upon the settlement of outstanding restricted share units, or RSUs, allocated or granted to directors, employees and consultants under the 2024 Plan, of which none were vested as of October 24, 2025; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000 Ordinary Shares issuable upon exercise of the warrants at an exercise price of $4.00 per share; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">670,000 Ordinary Shares issuable upon exercise of the warrants at an exercise price of $6.00 per share.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>An investment in our securities
involves a high degree of risk. Before making an investment in our securities, you should carefully consider all of the information included
or incorporated by reference into this prospectus, including the risks described under the heading &ldquo;Item 3. Key Information&mdash;
D. Risk Factors&rdquo; in our 2024 Annual Report, which we filed with the SEC on March 20, 2025, as updated by other reports and documents
we file with, or furnish to, the SEC and that are incorporated by reference herein. Please see the sections of this prospectus entitled
&ldquo;Where You Can Find Additional Information&rdquo; and &ldquo;Information Incorporated by Reference.&rdquo; If one or more of those
risks is realized, that could adversely impact our business, financial condition or results of operations.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We conduct our operations in Israel.&nbsp;Conditions
in Israel, including conditions affected by the recent attack by Hamas and other terrorist organizations and Israel&rsquo;s war against
them, may affect our operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
offices are located in Yokne&rsquo;am Illit, Israel, thus, political, economic, and military conditions in Israel may directly affect
our business. On October 7, 2023, Hamas terrorists infiltrated Israel&rsquo;s southern border from the Gaza Strip and conducted a series
of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers
located along Israel&rsquo;s border with the Gaza Strip and in other areas within the State of Israel. Following the attack, Israel&rsquo;s
security cabinet declared war against Hamas and the Israeli military began to call-up reservists for active duty. In January 2025, Israel
and Hamas entered into a ceasefire agreement, which remained in effect until March 18, 2025, when hostilities resumed. As of October 9,
2025, Israel and Hamas entered into a renewed ceasefire agreement calling for a permanent end of the war. However, there are no assurances
that such as agreement will hold. </FONT>&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">While the conflict has created
heightened security concerns, disruptions to business operations, and economic instability, the ceasefire may contribute to improved regional
stability. However, the security situation remains fluid, and any renewed military actions, restrictions, or government-imposed measures
could adversely affect our operations, supply chains, and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following the attack by Hamas
on Israel&rsquo;s southern border, Hezbollah, a terrorist organization in Lebanon, has also launched missile, rocket, and shooting attacks
against Israeli military sites, troops, and Israeli towns in northern Israel. In response to these attacks, the Israeli army has carried
out a number of targeted strikes on sites belonging to Hezbollah in southern Lebanon, and in October 2024, the Israeli military initiated
a ground operation in Lebanon, primarily near the Israel-Lebanon border. As of the end of November 2024, Israel entered into a ceasefire
agreement with Hezbollah, but there are no guarantees as to whether the agreement will hold or whether further hostilities will resume.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2024, Ba&rsquo;athist
Syria, led by President Bashar al-Assad, collapsed during a major offensive by opposition forces made up of several competing rebel groups.
In response, the Israeli Defense Forces took control over a United Nations-designated buffer zone over Mount Hermon that separated Israel
and Syria. Simultaneously, Israel conducted targeted military strikes against military assets in Syria, aiming to eliminate any chemical
weapons storage sites that could be used by rebel groups and further weaken Iran&rsquo;s operational capabilities in the region. While
the transitional government of Syria has indicated that it is interested in reconstruction and stability rather than a continuation of
conflicts with Israel, there are no guarantees that there is no future escalation of hostilities or that Syria will permit other neighboring
countries to launch attacks at Israel from its territory.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April 2024 and October
2024,&nbsp;Iran&nbsp;launched direct attacks on Israel involving hundreds of drones and missiles and has threatened to continue to attack
Israel. In June 2025, in light of continued nuclear threats and intelligence assessments indicating imminent attacks, Israel launched
a preemptive strike directly targeting military and nuclear infrastructure inside Iran aimed to disrupt Iran&rsquo;s capacity to coordinate
or launch further hostilities against Israel, as well as disrupt its nuclear program. As of June 24, 2025, there is a ceasefire between
Israel and Iran, but hostilities between Israel and Iran may further escalate, with both sides launching attacks against one another.
In addition, during the two-week fighting with Iran in June 2025, Israel closed its airspace and ceased all port activity related to commercial
shipments. In case of continued escalation, the functioning at our offices in Yokne&rsquo;am might be disrupted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is possible that other
terrorist organizations, including Palestinian military organizations in the West Bank, as well as other hostile countries, will join
the hostilities. Additionally, Iran may continue its direct aggression against Israel. Such hostilities may include terror and missile
attacks. Any hostilities involving Israel, or the interruption or curtailment of trade between Israel and its trading partners could adversely
affect our operations and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of today, these events
have had no material impact on the Company&rsquo;s operations. According to the recent guidelines of the Israeli government, the Company&rsquo;s
offices are open and functioning as usual. However, if the war escalates and expands to the Northern border with Lebanon, the Israeli
government potentially will impose additional restrictions on movement and travel, and our management and employees&rsquo; ability to
effectively perform their daily tasks might be temporarily disrupted, which may result in delays in some of our projects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company currently has
the supply of materials needed for its regular operations. While there may be some possible delays in supply, those are currently not
anticipated to be material to the Company&rsquo;s operations. However, if the war continues for a significant amount of time, this situation
may change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any hostilities involving
Israel, terrorist activities, political instability or violence in the region, or the interruption or curtailment of trade or transport
among Israel and its trading partners could make it more difficult for us to raise capital, if needed in the future, and adversely affect
our operations and results of operations and the market price of our Ordinary Shares. Moreover, we cannot predict how this war will ultimately
affect Israel&rsquo;s economy in general, which may involve a downgrade in Israel&rsquo;s credit rating by rating agencies (such as the
second downgrade by Moody&rsquo;s of its credit rating of Israel from A2 to Baa1 in September 2024).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our commercial insurance does
not cover losses that may occur as a result of an event associated with the security situation in the Middle East. Although the Israeli
government is currently committed to covering the reinstatement value of direct damages that are caused by terrorist attacks or acts of
war, we cannot assure you that this government coverage will be maintained or, if maintained, will be sufficient to compensate us fully
for damages incurred. Any losses or damages incurred by us could have a material adverse effect on our business, financial condition,
and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, many Israeli citizens
are obligated to perform several days, and in some cases, more, of annual military reserve duty each year until they reach the age of
40 (or older for certain reservists) and, in the event of a military conflict, may be called to active duty. In response to the series
of attacks on civilian and military targets in October 2023, there have been significant call-ups of military reservists. Currently, none
of the Company&rsquo;s employees are in military reserve service. However, if the number of reservists in our Company increases and becomes
significant, our operations could be disrupted by such call-ups.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any armed conflicts, terrorist
activities or political instability in the region could adversely affect business conditions, could harm our results of operations and
the market price of our Ordinary Shares, and could make it more difficult for us to raise capital. Parties with whom we do business may
sometimes decline to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative arrangements when
necessary, in order to meet our business partners face to face.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While the intensity and duration
of Israel&rsquo;s war against Hamas have been difficult to predict, the ceasefire marks a potential shift towards stability in the region.
If sustained, this could reduce disruptions to our business and the Israeli economy in general. However, if the war is renewed or expands
to other fronts, such as Lebanon, Syria and the West Bank, our operations may be harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B><I>Risks Relating to the
Offering and to an Investment in our Ordinary Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Shareholders may experience significant
dilution as a result of this offering and potential future offerings.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Purchasers of Ordinary Shares
in this offering, as well as our existing shareholders, may experience significant dilution due to the sale and issuance of shares at
prices below the price at which they invested. The Selling Shareholder identified herein is selling from time to time up to 3,322,000
Ordinary Shares underlying the New Warrants, which constitutes approximately 56.4% of our issued and outstanding Ordinary Shares prior
to the offering pursuant to this prospectus. The exercise price of the New Warrants is currently below the current trading price of our
Ordinary Shares, making it highly likely that the holder will elect to exercise them. If the New Warrants are exercised, our outstanding
Ordinary Shares would increase from 5,889,873 to 9,211,873, representing an increase of approximately 56.4% in the number of outstanding
Ordinary Shares. Accordingly, shareholders will experience significant dilution of their ownership interests. The resale of these additional
Ordinary Shares could also further cause the trading price of our Ordinary Shares to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, pursuant to two separate share purchase agreements entered into in September 2025, we have also issued to the Selling Shareholder
(i) warrants to purchase up to 1,000,000 Ordinary Shares at an exercise price of $4.00 per share and (ii) warrants to purchase up to 670,000
Ordinary Shares at an exercise price of $6.00 per share (together, the September 2025 Warrants). The respective exercise prices of the
aforementioned warrants are currently above the current trading price of our Ordinary Shares. The resale of these additional Ordinary
Shares could also further cause the trading price of our Ordinary Shares to decline.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, if all of the New
Warrants and the September 2025 Warrants are exercised, our outstanding Ordinary Shares would increase from 5,889,873 to 10,881,873, representing
an increase of approximately 84.8% in the number of outstanding Ordinary Shares. Accordingly, shareholders will experience significant
dilution of their ownership interests. The resale of these additional Ordinary Shares, or the perception that such issuances or resales
could occur, could also further cause the market price of Ordinary Shares to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we may issue
additional Ordinary Shares or other equity securities in the future in connection with, among other things, future acquisitions of additional
companies or assets, or under our equity incentive plans, in certain cases without shareholder approval. Any such issuance of additional
Ordinary Shares or other ordinary share equivalents would have the following effects:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our existing shareholders&rsquo; proportionate ownership interest in us will decrease;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the relative voting strength of each previously outstanding ordinary share may be diminished; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the market price of our Ordinary Shares may decline.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Future issuances or sales, or the potential
for future issuances or sales, of our Ordinary Shares may cause the trading price of our Ordinary Shares to decline and could impair our
ability to raise capital through subsequent equity offerings.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have issued a significant
number of Ordinary Shares and we may do so in the future. Shares to be issued in future equity offerings could cause the market price
of our Ordinary Shares to decline and could have an adverse effect on our earnings per share if and when we become profitable. In addition,
future sales of our Ordinary Shares or other securities in the public markets, or the perception that these sales may occur, could cause
the market price of our Ordinary Shares to decline, and could materially impair our ability to raise capital through the sale of additional
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market price of our Ordinary
Shares could decline due to sales, or the announcements of proposed sales, of a large number of Ordinary Shares in the market,&nbsp;including
sales of up to 3,322,000 Ordinary Shares issuable upon exercise of the New Warrants and sales of up to 1,670,000 Ordinary Shares issuable
upon the exercise of the September 2025 Warrants, or other sales of Ordinary Shares by our large shareholders, or the perception that
these sales could occur.&nbsp; These sales or the perception that these sales could occur could also depress the market price of our Ordinary
Shares and impair our ability to raise capital through the sale of additional equity securities or make it more difficult or impossible
for us to sell equity securities in the future at a time and price that we deem appropriate. We cannot predict the effect that future
sales of Ordinary Shares or other equity-related securities would have on the market price of our Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated articles
of association authorize our board of directors to, among other things, issue additional Ordinary Shares or securities convertible or
exchangeable into Ordinary Shares, without shareholder approval. We may issue such additional Ordinary Shares or convertible securities
to raise additional capital. The issuance of any additional Ordinary Shares or convertible securities could be substantially dilutive
to our shareholders. Moreover, to the extent that we issue restricted share units, stock appreciation rights, options or warrants to purchase
our Ordinary Shares in the future and those stock appreciation rights, options or warrants are exercised, or as the restricted share units
settle, our shareholders may experience further dilution. Holders of our Ordinary Shares have no preemptive rights that entitle such holders
to purchase their pro rata share of any offering of shares or equivalent securities and, therefore, such sales or offerings could result
in increased dilution to our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>An active trading market for our Ordinary
Shares may not be sustained.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although our Ordinary Shares
are listed on The Nasdaq Capital Market, the market for our Ordinary Shares has demonstrated varying levels of trading activity. Furthermore,
the current level of trading may not be sustained in the future. The lack of an active market for our Ordinary Shares may impair investors&rsquo;
ability to sell their shares at the time they wish to sell them or at a price that they consider reasonable, may reduce the fair market
value of their shares and may impair our ability to raise capital to continue to fund operations by selling shares and may impair our
ability to utilize our shares as consideration in any licensing or other collaboration transactions with third parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our share price may be subject to substantial
volatility, and shareholders may lose all or a substantial part of their investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Ordinary Shares currently
trade on The Nasdaq Capital Market. There is limited public float, and trading volume historically has been low and sporadic. As a result,
the market price for our Ordinary Shares may not necessarily be a reliable indicator of our fair market value. The price at which our
Ordinary Shares trades may fluctuate as a result of a number of factors, including the number of shares available for sale in the market,
quarterly variations in our operating results, actual or anticipated announcements of new releases by us or competitors, the gain or loss
of sources of revenues, changes in the estimates of our operating performance, market conditions in our industry and the economy as a
whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Because we do not anticipate paying any
cash dividends on our Ordinary Shares in the foreseeable future, capital appreciation, if any, will be your sole source of gain.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never paid or declared
any cash dividends on our Ordinary Shares. We currently intend to retain earnings, if any, to finance the growth and development of our
business and we do not anticipate paying any cash dividends in the foreseeable future. As a result, only appreciation of the price of
our Ordinary Shares will provide a return to our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Resales of our Ordinary Shares in the public
market during this offering by our shareholders may cause the market price of our Ordinary Shares to fall.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales of a substantial number
of our Ordinary Shares could occur at any time. The issuance of new Ordinary Shares could result in resales of our Ordinary Shares by
our current shareholders concerned about the potential ownership dilution of their holdings. In turn, these resales could have the effect
of depressing the market price for our Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and the documents
incorporated by reference in this prospectus and contain, and our officers and representatives may from time to time make, &ldquo;forward-looking
statements,&rdquo; which include information relating to future events, future financial performance, financial projections, strategies,
expectations, competitive environment and regulation. Words such as &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;could,&rdquo; &ldquo;would,&rdquo;
&ldquo;predicts,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo; &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;future,&rdquo;
&ldquo;intends,&rdquo; &ldquo;plans,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;goal,&rdquo; &ldquo;seek,&rdquo; &ldquo;project,&rdquo;
&ldquo;strategy,&rdquo; &ldquo;likely,&rdquo; and similar expressions, as well as statements in future tense, identify forward-looking
statements. Forward-looking statements are neither historical facts, nor should they be read as a guarantee of future performance or results
and may not be accurate indications of when such performance or results will be achieved. Forward-looking statements are based on information
we have when those statements are made or management&rsquo;s good faith belief as of that time with respect to future events, and are
subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested
by the forward-looking statements. Important factors that could cause such differences include, but are not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our financial statements for the year ended December 31, 2024, contained an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern, which could prevent us from obtaining new financing on reasonable terms or at all;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SNC becoming the industry standard input method for wearable computing and consumer electronics;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain and expand our existing customer base;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain and expand compatibility of our devices with a broad range of mobile devices and operating systems;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain our business models;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to correctly predict the market growth;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to remediate material weaknesses in our internal control over financial reporting;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to retain our founders;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain, protect, and enhance our intellectual property;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to raise capital through the issuance of additional securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the impact of competition and new technologies;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to comply with Nasdaq listing requirements; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the global political and economic environment in countries in which we operate including those related to recent unrest and actual or potential armed conflict in Israel and other parts of the Middle East, such as the Israel-Gaza Strip war, the war with Iran and conflicts with Hezbollah in Lebanon;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in our strategy;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other risks and uncertainties, including those factors referred to in &ldquo;Item 3. Key Information - D. Risk Factors,&rdquo; &ldquo;Item 4. Information on the Company,&rdquo; and &ldquo;Item 5. Operating and Financial Review and Prospects&rdquo;, in our 2024 Annual Report.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These statements are only
current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our or our industry&rsquo;s
actual results, levels of activity, performance or achievements to be materially different from those anticipated by the forward-looking
statements. We discuss many of these risks in this prospectus in greater detail under the heading &ldquo;Risk Factors&rdquo; and elsewhere
in this prospectus and the documents incorporated by reference herein. You should not rely upon forward-looking statements as predictions
of future events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we believe that the
expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance,
or achievements. Except as required by law, we are under no duty to update or revise any of the forward-looking statements, whether as
a result of new information, future events or otherwise, after the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Moreover, new risks regularly
emerge and it is not possible for our management to predict or articulate all risks we face, nor can we assess the impact of all risks
on our business or the extent to which any risk, or combination of risks, may cause actual results to differ from those contained in any
forward-looking statements. The Private Securities Litigation Reform Act of 1995 and Section 27A of the Securities Act do not protect
any forward-looking statements that we make in connection with this offering. All forward-looking statements included in this prospectus
and the documents incorporated by reference herein and therein are based on information available to us as of the date of this prospectus
or the date of the applicable document incorporated by reference. Except to the extent required by applicable laws or rules, we undertake
no obligation to publicly update or revise any forward-looking statement, whether written or oral, that may be made from time to time,
whether as a result of new information, future events or otherwise. All subsequent written and oral forward-looking statements attributable
to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained above and throughout
this prospectus and the documents incorporated by reference in this prospectus. We qualify all of our forward-looking statements by these
cautionary statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN ADDITION TO THE ABOVE RISKS,
BUSINESSES ARE OFTEN SUBJECT TO RISKS NOT FORESEEN OR FULLY APPRECIATED BY OUR MANAGEMENT. IN REVIEWING THIS PROSPECTUS AND THE DOCUMENTS
INCORPORATED BY REFERENCE HEREIN AND THEREIN, POTENTIAL INVESTORS SHOULD KEEP IN MIND THAT THERE MAY BE OTHER POSSIBLE RISKS THAT COULD
BE IMPORTANT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will not receive any proceeds
from the sale of the Ordinary Shares by the Selling Shareholder. We will, however, receive up to a gross aggregate amount of approximately
$5.7 million in cash from the exercise of the New Warrants, assuming the exercise in full for cash of all the New Warrants, which we intend
to use for working capital and general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholder will
receive all of the net proceeds from the sale of any Ordinary Shares offered by it under this prospectus. See &ldquo;Selling Shareholder.&rdquo;
The Selling Shareholder will pay any underwriting discounts and commissions and expenses incurred by the Selling Shareholder for brokerage,
accounting, tax, legal services or any other expenses incurred by the Selling Shareholder in disposing of these Ordinary Shares. We will
bear all other costs, fees and expenses incurred in effecting the registration of the sale of the Ordinary Shares covered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_006"></A>capitalization
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
our cash and cash equivalents and our capitalization as of June 30, 2025:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on an actual basis;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on a pro forma basis to give effect to the (i) the receipt of net proceeds of $2.2 million and the issuance of 1,661,000 Ordinary Shares that were issued in August 2025 as part of a warrant inducement transaction, (ii) the receipt of net proceeds of $3.5 million and the issuance of 440,000 Ordinary Shares and 560,000 Ordinary Shares issued upon the exercise of pre-funded warrants in connection with the registered direct offering and private placement that closed on September 12, 2025, (iii) the receipt of net proceeds of $3.54 million and the issuance of 440,000 Ordinary Shares and 230,000 Ordinary Shares issued upon the exercise of pre-funded warrants in connection with the registered direct offering and private placement that closed on September 15, 2025, (iv) the issuance of an aggregate of 36,601 Ordinary Shares upon the settlement of RSUs from July through October 2025, and (v) the receipt of net proceeds of $876,000 and the issuance of 234,439 Ordinary Shares pursuant to an at-the-market sales agreement dated September 25, 2025, as of October 24, 2025; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on a&nbsp;<I>pro forma</I>&nbsp;as adjusted basis to give effect to the items above and the full exercise of the New Warrants issued pursuant to the August 2025 private placement. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table should
be read in conjunction with &ldquo;<I>Use of Proceeds</I>,&rdquo; our financial statements and related notes that are incorporated by
reference into this prospectus and the other financial information included or incorporated by reference into this form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of June 30, 2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic">U.S. dollars in thousands</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Actual</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: center">Pro forma</TD><TD STYLE="font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: center">Pro forma<BR> as adjusted</TD><TD STYLE="font-weight: bold; font-style: italic">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; padding-bottom: 1.5pt">Cash</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">2,064</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">12,177</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">17,821</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Long term debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Shareholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Share capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Additional paid in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,563</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,676</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,320</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Accumulated losses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(32,817</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(32,817</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(32,817</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total shareholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,813</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,926</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">19,570</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total capitalization</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,813</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,926</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">19,570</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This above table is based
on 2,287,833 Ordinary Shares outstanding as of June 30, 2025, and excludes, as of such date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,222 Ordinary Shares issuable upon the exercise of outstanding options allocated or granted to directors, employees and consultants under the 2015 Plan, at a weighted average exercise price of $31.62 per Ordinary Share, of which 17,326 were vested as of October 24, 2025; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">277 Ordinary Shares issuable upon the exercise of warrants issued to a consultant, at an exercise price of $180.00 per share, which are all vested as of October 24, 2025, and an additional 295 Ordinary Shares issuable upon the exercise of warrants issued to an advisor, at an exercise price of $338.40 per share&#894;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,976 Ordinary Shares reserved for future issuance under the 2015 Plan; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,589 Ordinary Shares issuable upon the exercise of 98,589 IPO Warrants, at an exercise price of $160.00 per share and warrants to purchase up to 2,344 Ordinary Shares, issued to the underwriter in our initial public offering, or IPO, at an exercise price of $424.80 per share; &nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 Ordinary Shares reserved for issuance under the SEPA;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,500 Ordinary Shares reserved for future issuance under the 2024 Purchase Plan; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">157,627 Ordinary Shares reserved for future issuance under the 2024 Plan;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">554,888 Ordinary Shares issuable upon the settlement of outstanding RSUs, allocated or granted to directors, employees and consultants under the 2024 Plan, of which none were vested as of October 24, 2025;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000 Ordinary Shares issuable upon exercise of the warrants at an exercise price of $4.00 per share that were issued after June 30, 2025; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">670,000 Ordinary Shares issuable upon exercise of the warrants at an exercise price of $6.00 per share that were issued after June 30, 2025.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>SELLING SHAREHOLDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus relates to
the sale of up to 3,322,000 Ordinary Shares that the Selling Shareholder may sell in one or more offerings upon exercise of some or all
of New Warrants that the Selling Shareholder received from us, following the approval of our shareholders, pursuant to the August 2025
warrant inducement and private placement of New Warrants described above. The table below sets forth information about the maximum number
of Ordinary Shares that may be offered from time to time by the Selling Shareholder under this prospectus. The Selling Shareholder identified
below may currently hold or acquire Ordinary Shares in addition to those registered hereby. In addition, the Selling Shareholder identified
below may sell, transfer, assign or otherwise dispose of some or all of its Ordinary Shares registered hereunder in private placement
transactions exempt from or not subject to the registration requirements of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To our knowledge, the Selling
Shareholder does not have, and has not had within the past three years, any position, office or other material relationship with us or
any of our predecessors or affiliates, other than its ownership of our Ordinary Shares and New Warrants and other warrants. The Selling
Shareholder has purchased our securities in certain of our prior financing transactions and also participated in the transaction giving
rise to this offering. In addition, to our knowledge, the Selling Shareholder is not an affiliate of a broker-dealer and there are no
participating broker-dealers. To the extent a selling shareholder would be an affiliate of a broker-dealer, or if there would be any participating
broker-dealer, such selling shareholder and/or participating broker-dealer would be deemed to be an &ldquo;underwriter&rdquo; within the
meaning of the Securities Act, and any commissions or discounts given to any such selling shareholder or broker-dealer could be regarded
as underwriting commissions or discounts under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to entering into the
Inducement Agreement, the Company had 2,306,082 Ordinary Shares issued and outstanding. On August 7, 2025, we closed the transaction contemplated
by the Inducement Agreement between us and the Selling Shareholder, which consisted of two separate, concurrent transactions &mdash; (i)
a warrant inducement and (ii) a private placement. As of October 24, 2025, the Company had 5,889,873 Ordinary Shares issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the warrant inducement,
the Selling Shareholder exercised 1,661,000 Existing Warrants to purchase 1,661,000 Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In a concurrent private placement
effected pursuant to the Inducement Agreement, we sold 3,322,000 New Warrants to the Selling Shareholder, each of which is exercisable
for one Ordinary Share, which were issued to the Selling Shareholder on October 24, 2025, following approval by our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the aggregate, the warrant
inducement and private placement transactions contemplated by the Inducement Agreement resulted in our issuance of 1,661,000 Ordinary
Shares, which constituted approximately 72.0% of the issued and outstanding shares of the Company prior to the transactions. In addition,
if the New Warrants are fully exercised, we would issue an additional 3,322,000 Ordinary Shares, which would constitute approximately
56.4% of our issued and outstanding Ordinary Shares as of October 24, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have prepared the following
table based on information supplied to us by the Selling Shareholder on or prior to October 20, 2025.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may amend or supplement
this prospectus from time to time in the future to update or change the selling shareholders list and the securities that may be resold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares <BR> Beneficially Owned &nbsp;<BR> Prior to Offering<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Maximum<BR> Number of<BR> Shares to<BR> be Sold<BR> Pursuant &nbsp;<BR> to this<BR> Prospectus</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares Owned<BR> Immediately After Sale of <BR> Maximum Number of <BR> Shares in this Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name of Selling Shareholder</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage<SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number<SUP>(3)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage<SUP>(4)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Armistice Capital, LLC<B><SUP>(5)</SUP></B></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4,992,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">45.9</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,322,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,670,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">15.3</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included as Ordinary Shares &ldquo;owned&rdquo; for purposes of this column are the (i) 3,322,000 Ordinary Shares issuable upon the exercise of the New Warrants, (ii) 1,000,000 Ordinary Shares issuable upon the exercise of warrants, exercisable at a price of $4.00 per share, and (iii) 670,000 Ordinary Shares issuable upon the exercise of warrants, exercisable at an exercise price of $6.00 per share, held by the Selling Shareholder. The September 2025 Warrants provide that the Selling Shareholder may not hold more than 4.99% of the total issued and outstanding Ordinary Shares of the Company at any given time.</FONT></TD></TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The percentage ownership of 45.9% is based on 5,889,873 outstanding Ordinary Shares as of the date of this prospectus, while also including as outstanding for purposes of calculating such percentage, an additional 3,322,000 Ordinary Shares underlying the New Warrants held by the Selling Shareholder, and 1,670,000 Ordinary Shares underlying the September 2025 Warrants held by the Selling Shareholder which are also currently exercisable. This percentage does not give effect to the provisions of each of the foregoing New Warrants, which provide that the Selling Shareholder may not hold more than 4.99% (or, if elected prior to issuance, 9.99%) of the total issued and outstanding Ordinary Shares of the Company at any given time. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes that the Selling Shareholder will sell all of the 3,322,000 Ordinary Shares underlying New Warrants that are being offered pursuant to this prospectus. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The percentage of outstanding Ordinary Shares which may be sold in this offering considers, as outstanding Ordinary Shares, the 3,322,000 Ordinary Shares underlying the New Warrants that may be sold in this offering.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The securities are directly held by Armistice Capital Master Fund Ltd., a Cayman Islands exempted company, or the Master Fund, and may be deemed to be beneficially owned by: (i) Armistice Capital, LLC, or Armistice Capital, as the investment manager of the Master Fund; and (ii) Steven Boyd,&nbsp;as the Managing Member of Armistice Capital. The New Warrants are subject to a beneficial ownership limitation of 4.99%, which such limitation restricts the Selling Shareholder from exercising that portion of the New Warrants that would result in the Selling Shareholder and its affiliates owning, after exercise, a number of shares of Ordinary Shares in excess of the beneficial ownership limitation. The address of Armistice Capital Master Fund Ltd. is c/o Armistice Capital, LLC, 510 Madison Avenue, 7th Floor, New York, NY 10022.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_008"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are registering the sale
of the 3,322,000 Ordinary Shares (underlying the New Warrants) offered under this prospectus on behalf of the Selling Shareholder. The
Selling Shareholder, which, as used herein includes donees, pledgees, transferees, or other successors-in-interest selling those Ordinary
Shares or interests in those Ordinary Shares received after the date of this prospectus from the Selling Shareholder as a gift, pledge,
partnership distribution, or other non-sale related transfer, may, from time to time, sell, transfer, or otherwise dispose of any or all
of the subject Ordinary Shares on any stock exchange, market or trading facility on which the Ordinary Shares are traded or in private
transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing
market price, at varying prices determined at the time of sale, or at negotiated prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholder may,
from time to time, pledge or grant a security interest in some or all of the subject Ordinary Shares owned by such shareholder and, if
it defaults in the performance of its secured obligations, the pledgees or secured parties may offer and sell the subject Ordinary Shares,
from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision
of the Securities Act amending the list of the Selling Shareholder(s) to include the pledgee, transferee, or other successors in interest
as a Selling Shareholder under this prospectus. The Selling Shareholder may use any one or more of the following methods when disposing
of its shares pursuant to this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately negotiated transactions;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement of short sales;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in transactions through broker-dealers that agree with the Selling Shareholder to sell a specified number of such securities at a stipulated price per security;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a combination of any such methods of sale; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of Ordinary Shares or interests therein, the Selling Shareholder may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the Ordinary Shares in the course of hedging the positions they assume. The Selling
Shareholder may also sell Ordinary Shares short and deliver these securities to close out its short positions, or loan or pledge the Ordinary
Shares to broker-dealers that in turn may sell these securities. The Selling Shareholder may also enter into option or other transactions
with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to
such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial
institution may resell pursuant to this prospectus (as amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Ordinary Shares are
sold through broker dealers, the Selling Shareholder will be responsible for discounts or commissions or agent&rsquo;s commissions. The
aggregate proceeds to the Selling Shareholder from the sale of the Ordinary Shares offered by it will be the purchase price of the Ordinary
Shares less discounts or commissions, if any. The Selling Shareholder reserves the right to accept and, together with its agents from
time to time, to reject, in whole or in part, any proposed purchase of Ordinary Shares to be made directly or through agents. We will
not receive any of the proceeds from this offering (although we will receive proceeds from the exercise of the Warrants under which the
Ordinary Shares being sold in this offering will be issued).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholder also
may resell all or a portion of the Ordinary Shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided
that it meets the criteria and conforms to the requirements of that rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholder and
any underwriters, broker-dealers, or agents that participate in the sale of our Ordinary Shares or interests therein may be deemed to
be &ldquo;underwriters&rdquo; within the meaning of Section 2(a)(11) of the Securities Act. Any discounts, commissions, concessions, or
profit they earn on any resale of the shares may be deemed to be underwriting discounts and commissions under the Securities Act. If the
Selling Shareholder is deemed an &ldquo;underwriter&rdquo; within the meaning of Section 2(a)(11) of the Securities Act, it will be subject
to the prospectus delivery requirements of the Securities Act. We will make copies of this prospectus (as it may be amended from time
to time) available to the Selling Shareholder for the purpose of satisfying the prospectus delivery requirements of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent required, the
Ordinary Shares to be sold, the respective purchase prices and public offering prices, the names of any agents, dealers, or underwriters,
and any applicable commissions or discounts with respect to a particular offer will be set forth, if appropriate, in a post-effective
amendment to the registration statement that includes this prospectus or, to the extent permissible, in a supplement to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to comply with the
securities laws of some states, if applicable, the Ordinary Shares to be sold under this prospectus may be sold in these jurisdictions
only through registered or licensed brokers or dealers. In addition, in some states the Ordinary Shares may not be sold unless they have
been registered or qualified for sale or an exemption from registration or qualification requirements is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholder and
any other person participating in a distribution of the Ordinary Shares covered by this prospectus will be subject to the applicable provisions
of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales
of any of the Ordinary Shares by the Selling Shareholder and any other such person. To the extent applicable, Regulation M may also restrict
the ability of any person engaged in the distribution of the Ordinary Shares under this prospectus to engage in market-making activities
with respect to the Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Offer Restrictions Outside the United States</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than in the United States,
no action has been taken by us or the Selling Shareholder that would permit a public offering of the securities offered by this prospectus
in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly
or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such
securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable
rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about
and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute
an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer
or a solicitation is unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_009"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal matters with
respect to Israeli law and with respect to the validity of the offered securities under Israeli law will be passed upon for us by Sullivan
&amp; Worcester Tel Aviv (Har-Even &amp; Co.), Tel Aviv, Israel. Certain legal matters with respect to U.S. law will be passed upon for
us by Sullivan &amp; Worcester LLP, New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements of Wearable Devices Ltd. as of December 31, 2024 and 2023 and for each of the three years in the period ended December 31,
2024 incorporated by reference herein, have been incorporated in reliance on the report of Ziv Haft, Certified Public Accountants, Isr.,
BDO Member Firm, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.
The report on the consolidated financial statements contains an explanatory paragraph regarding the Company&rsquo;s ability to continue
as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>EXPENSES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following are the estimated
expenses of this offering payable by us related to the filing of the registration statement of which this prospectus forms a part. With
the exception of the SEC registration fee, all amounts are estimates and may change:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">SEC registration fee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,201.97</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Printer fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounting fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">37,201.97</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>ENFORCEABILITY OF CIVIL LIABILITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are incorporated under
the laws of the State of Israel. Service of process upon us and upon our directors and officers and the Israeli experts named in the registration
statement of which this prospectus forms a part, a substantial majority of whom reside outside of the United States, may be difficult
to obtain within the United States. Furthermore, because substantially all of our assets and a substantial of our directors and officers
are located outside of the United States, any judgment obtained in the United States against us or any of our directors and officers may
not be collectible within the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have been informed by our
legal counsel in Israel, Sullivan &amp; Worcester Tel Aviv (Har-Even &amp; Co.), that it may be difficult to assert U.S. securities law
claims in original actions instituted in Israel. Israeli courts may refuse to hear a claim based on a violation of U.S. securities laws
because Israel is not the most appropriate forum to bring such a claim. In addition, even if an Israeli court agrees to hear a claim,
if U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a fact which can be a time-consuming and costly
process. Certain matters of procedure will also be governed by Israeli law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to specified time
limitations and legal procedures, Israeli courts may enforce a U.S. judgment in a civil matter which, subject to certain exceptions, is
non-appealable, including judgments based upon the civil liability provisions of the Securities Act and the Exchange Act and including
a monetary or compensatory judgment in a non-civil matter, provided that among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment is obtained after due process before a court of competent jurisdiction, according to the laws of the state in which the judgment is given;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment is final and is not subject to any right of appeal;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the prevailing law of the foreign state in which the judgment was rendered allows for the enforcement of judgments of Israeli courts. However, the court may enforce a foreign judgment, even without reciprocity, based on the request of the Attorney General, under certain circumstances;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the liabilities under the judgment are enforceable according to the laws of the State of Israel and the judgment and the enforcement of the civil liabilities set forth in the judgment are not contrary to the public policy in Israel;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment was not obtained by fraud, there was a reasonable opportunity for the defendant to present their case, the judgment was given by an authorized court to issue it under the applicable international private law rules in Israel, the judgement does not conflict with any other valid judgments in the same matter between the same parties;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an action between the same parties in the same matter is not pending in any Israeli court at the time the lawsuit is instituted in the foreign court; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment is enforceable according to the laws of the foreign state in which the relief was granted; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enforcement may be denied if it could harm the sovereignty or security of Israel.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a foreign judgment is declared
enforceable by an Israeli court, it generally will be payable in Israeli currency. The conversion to Israeli currency will be based on
the latest official exchange rate published by the Bank of Israel before the payment date. However, the obligated party will fulfil its
duty by the judgment even if they choose to make the payment in the same foreign currency, subject to the laws governing the foreign currency
applicable at that time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pending collection, the amount
of the judgment of an Israeli court stated in Israeli currency ordinarily will be linked to the Israeli CPI plus interest at the annual
statutory rate set by Israeli regulations prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange rates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_013"></A>WHERE YOU CAN FIND ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an Israeli company
and are a &ldquo;foreign private issuer&rdquo; as defined in Rule 3b-4 under the Exchange Act. As a foreign private issuer, we are exempt
from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal
shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we are not required
under the Exchange Act to file annual, quarterly and current reports and financial statements with the SEC as frequently or as promptly
as U.S. companies whose securities are registered under the Exchange Act. However, we file with the SEC, within 120 days after the end
of each fiscal year, or such applicable time as required by the SEC, an annual report on Form 20-F containing financial statements audited
by an independent registered public accounting firm, and submit to the SEC, on a Form 6-K, unaudited interim financial information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a corporate website
at https://www.wearabledevices.co.il. We will post on our website any materials required to be so posted on such website under applicable
corporate or securities laws and regulations, including any notices of general meetings of our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC also maintains a web
site that contains information we file electronically with the SEC, which you can access over the Internet at http://www.sec.gov. Information
contained on, or that can be accessed through, our website and other websites listed in this prospectus do not constitute a part of this
prospectus. We have included these website addresses in this prospectus solely as inactive textual references.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is part of
a registration statement on Form F-3 filed by us with the SEC under the Securities Act. As permitted by the rules and regulations of the
SEC, this prospectus does not contain all the information set forth in the registration statement and the exhibits thereto filed with
the SEC. For further information with respect to us and the securities offered hereby, you should refer to the complete registration statement
on Form F-3, which may be obtained from the locations described above. Statements contained in this prospectus or in any prospectus supplement
about the contents of any contract or other document are not necessarily complete. If we have filed any contract or other document as
an exhibit to the registration statement or any other document incorporated by reference in the registration statement, you should read
the exhibit for a more complete understanding of the document or matter involved. Each statement regarding a contract or other document
is qualified in its entirety by reference to the actual document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_014"></A>INFORMATION INCORPORATED BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate
by reference&rdquo; the information we file with it, which means that we can disclose important information to you by referring you to
those documents. The information incorporated by reference is considered to be part of this prospectus and information we file later with
the SEC will automatically update and supersede this information. The documents we are incorporating by reference as of their respective
dates of filing are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Annual Report on <U><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025025602/ea0234654-20f_wearable.htm">Form 20-F</A></U> for the fiscal year ended December 31, 2024, filed with the SEC on March 20, 2025; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Reports of Foreign
    Private Issuer on Form 6-K furnished to the SEC on <U><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025029160/ea0237329-6k_wearable.htm">April
    7, 2025</A></U>, <U><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025034349/ea0239217-6k_wearable.htm">April 23,
    2025</A></U>, <U><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025037054/ea0240066-6k_wearable.htm">April 30,
    2025</A></U>, <U><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025046601/ea0243199-6k_wearable.htm">May 22,
    2025</A></U>, <U><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025070913/ea0251496-6k_wearable.htm">August 4,
    2025</A></U> (with respect to the first four, sixth, and seventh paragraphs and the section titled &ldquo;Forward-Looking
    Statements&rdquo; in the press release attached as Exhibit 99.1), <A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025072855/ea0252123-6k_wearable.htm">August
    7, 2025</A>, &nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025073950/ea0252613-6k_wearable.htm">August 11,
    2025</A> (with respect to the first two, fourth, and fifth paragraphs and section titled &ldquo;Forward-Looking Statements&rdquo; in
    the press release attached as Exhibit 99.1); <A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025086155/ea0255783-6k_wearable.htm">September
    9, 2025</A> (other than the second, third, fourth and fifth paragraphs in the press release attached as Exhibit 99.3); <A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025086386/ea0256797-6k_wearable.htm">September
    10, 2025</A> (with respect to the first six and ninth paragraph and the section titled &ldquo;Forward-Looking Statements
    Disclaimer&rdquo; in the press release attached as Exhibit 99.1); <A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025086848/ea0256950-6k_wearable.htm">September
    11, 2025</A>; <A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025087408/ea0257315-6k_wearable.htm">September 15,
    2025</A>; <A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025089525/ea0258021-6k_wearable.htm">September 19,
    2025</A>; <A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025091719/ea0258740-6k_wearable.htm">September 25,
    2025</A>; and <A HREF="https://www.sec.gov/Archives/edgar/data/1887673/000121390025101913/ea0262421-6k_wearable.htm">October 24, 2025</A>; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The description of our securities contained in <U><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390022055087/ea165606-8a12b_wearable.htm">Form 8-A</A></U>, File No. 001-41502, filed with the SEC on September 9, 2022, as amended by <U><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025025602/ea023465401ex2-7_wearable.htm">Exhibit 2.7</A></U>&nbsp;to our Annual Report on <U><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025025602/ea0234654-20f_wearable.htm">Form 20-F</A></U> for the fiscal year ended December 31, 2024, filed with the SEC on March 20, 2025, including any further amendments or reports filed for the purpose of updating such description.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All subsequent annual reports
filed by us pursuant to the Exchange Act on Form 20-F (1)&nbsp;after the date of the filing of the registration statement of which this
prospectus forms a part and prior to its effectiveness and (2) prior to the termination of the offering shall be deemed to be incorporated
by reference to this prospectus and to be a part hereof from the date of filing of such documents. We may also incorporate part or all
of any Form 6-K subsequently submitted by us to the SEC after the date of the filing of the registration statement of which this prospectus
forms a part and prior to its effectiveness and prior to the termination of the offering by identifying in such Forms 6-K that they, or
certain parts of their contents, are being incorporated by reference herein, and any Forms 6-K so identified shall be deemed to be incorporated
by reference in this prospectus and to be a part hereof from the date of submission of such documents. Any statement contained in a document
incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus
to the extent that a statement contained herein or in any other subsequently filed document which also is incorporated or deemed to be
incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide to each person,
including any beneficial owner, to whom this prospectus is delivered, a copy of these filings, at no cost, upon written or oral request
to us at the following address: 5 Ha-Tnufa St., Yokne&rsquo;am Illit, 2066736, Israel, Tel: +972.4.6185670, Attention: Chief Financial
Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WEARABLE DEVICES LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Up to 3,322,000 <FONT STYLE="background-color: white">Ordinary
Shares</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item&nbsp;8. Indemnification of Directors and Officers </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Indemnification</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Israeli Companies Law
5759-1999, or the Companies Law, and the Israeli Securities Law, 5728-1968, or the Securities Law, provide that a company may indemnify
an office holder against the following liabilities and expenses incurred for acts performed by him or her as an office holder, either
pursuant to an undertaking made in advance of an event or following an event, provided its articles of association include a provision
authorizing such indemnification:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
financial liability imposed on him or her in favor of another person by any judgment concerning an act performed in his or her capacity
as an office holder, including a settlement or arbitrator&rsquo;s award approved by a court;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable
litigation expenses, including attorneys&rsquo; fees, expended by the office holder (a) as a result of an investigation or proceeding
instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (1) no indictment
(as defined in the Companies Law) was filed against such office holder as a result of such investigation or proceeding; and (2) no financial
liability as a substitute for the criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result of such
investigation or proceeding, or, if such financial liability was imposed, it was imposed with respect to an offense that does not require
proof of criminal intent; or (b) in connection with a monetary sanction;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable
litigation expenses, including attorneys&rsquo; fees, expended by the office holder or imposed on him or her by a court; (1) in proceedings
that the company institutes, or that another person institutes on the company&rsquo;s behalf, against him or her; (2) in a criminal proceeding
of which he or she was acquitted; or (3) as a result of a conviction for a crime that does not require proof of criminal intent; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses
incurred by an office holder in connection with an Administrative Procedure under the Securities Law, including reasonable litigation
expenses and reasonable attorneys&rsquo; fees. An &ldquo;Administrative Procedure&rdquo; is defined as a procedure pursuant to chapters
H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement
Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures subject to conditions) to the Securities Law.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law also permits
a company to add provisions in the articles of association, to undertake in advance to indemnify an office holder, provided that if such
indemnification relates to financial liability imposed on him or her, as described above, then the undertaking should be limited and shall
detail the following foreseen events and amount or criterion:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
events that in the opinion of the board of directors can be foreseen based on the company&rsquo;s activities at the time that the undertaking
to indemnify is made; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.7pt; text-align: justify; text-indent: -13.7pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
amount or criterion determined by the board of directors, at the time of the giving of such undertaking to indemnify, to be reasonable
under the circumstances</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into indemnification
agreements with all of our directors and with all members of our senior management. Each such indemnification agreement shall provide
the office holder with indemnification permitted under applicable law and up to a certain amount, and to the extent that these liabilities
are not covered by directors and officers insurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exemption</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, an
Israeli company may not exempt an office holder from liability for a breach of his or her duty of loyalty, but may exempt in advance an
office holder from his or her liability to the company, in whole or in part, for damages caused to the company as a result of a breach
of his or her duty of care (other than in relation to distributions), but only if a provision authorizing such exemption is included in
its articles of association. Our amended and restated articles of association provide that we may exempt, in whole or in part, any office
holder from liability to us for damages caused to the company as a result of a breach of his or her duty of care. Subject to the aforesaid
limitations, and to other limitations detailed in the indemnification agreements, we exempt and release our office holders from any and
all liability to us related to any breach by them of their duty of care to us to the fullest extent permitted by law.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Limitations&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">The
Companies Law provides that </FONT>we <FONT STYLE="background-color: white">may not exempt or indemnify an office holder nor enter into
an insurance contract that would provide coverage for any liability incurred as a result of any of the following: (1) a breach by the
office holder of his or her duty of loyalty unless (in the case of indemnity or insurance only, but not exemption) the office holder acted
in good faith and had a reasonable basis to believe that the act would not prejudice us; (2) a breach by the office holder of his or her
duty of care if the breach was carried out intentionally or recklessly (as opposed to merely negligently); (3) any act or omission committed
with the intent to derive an illegal personal benefit; or (4) any fine, monetary sanction, penalty or forfeit levied against the office
holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Under
the Companies Law, exemption, indemnification and insurance of office holders in a public company must be approved by the compensation
committee and the board of directors (and, with respect to certain office holders or under certain circumstances, also by the shareholders).
However, under regulations promulgated under the Companies Law, the insurance of office holders shall not require shareholder approval
and may be approved by only the compensation committee, if the engagement terms are determined in accordance with the company&rsquo;s
compensation policy that was approved by the shareholders by the same special majority required to approve a compensation policy, provided
that the insurance policy is on market terms and the insurance policy is not likely to materially impact the company&rsquo;s profitability,
assets or obligations. In addition, under regulations promulgated under the Companies Law, with respect to the insurance of office holders
of a company in which there is a controlling shareholder who is also an office holder, a board approval is also required, subject to meeting
the aforesaid conditions.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated articles
of association permit us to exempt (subject to the aforesaid limitation), indemnify and insure our office holders to the fullest extent
permitted or to be permitted by the Companies Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9. Exhibits</B>&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: top; width: 8%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B>&nbsp;<B><BR>
Number</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 91%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1 </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1887673/000121390025101913/ea026242101ex99-2_wearable.htm">Amended and Restated Articles of Association of Wearable Devices Ltd. (filed as Exhibit 99.2 to Form 6-K (File No. 001-41502) filed on October 24, 2025 and incorporated herein by reference).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025072855/ea025212301ex4-1_wearable.htm">Form of New Warrant (filed as Exhibit 4.1 to Form 6-K (File No. 001-41502) filed on August 7, 2025 and incorporated herein by reference).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea026255801ex5-1_wearable.htm">Opinion of Sullivan &amp; Worcester Tel Aviv (Har-Even &amp; Co.), Israeli counsel to Wearable Devices Ltd.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1887673/000121390025072855/ea025212301ex10-1_wearable.htm">Form of Inducement Letter (filed as Exhibit 10.1 to Form 6-K (File No. 001-41502) filed on August 7, 2025 and incorporated herein by reference).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea026255801ex23-1_wearable.htm">Consent of Ziv Haft, Certified Public Accountants, Isr., BDO member firm, an independent registered public accounting firm.</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2* </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea026255801ex5-1_wearable.htm">Consent of Sullivan &amp; Worcester Tel Aviv (Har-Even &amp; Co.) (included in Exhibit 5.1)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1* </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_015">Power of Attorney (included on the signature page to the initially filed Registration Statement on Form F-3)</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107* </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea026255801ex-fee_wearable.htm">Filing Fee Table</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
herewith.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 10. Undertakings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a) The undersigned Registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">To file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration
Fee&rdquo; table in the effective registration statement.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To include any material information with respect
    to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration
    statement; &nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">provided, <I>however</I>, that paragraphs (a)(1)(i),
    (a)(1)(ii) and a(l)(iii) do not apply if the registration statement is on Form S-3 or Form F-3 and the information required to be included
    in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant
    to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement,
    or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) That, for the purpose
of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
<I>bona fide</I> offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3) To remove from registration
by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4) To file a post-effective
amendment to the registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed
offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act need
not be furnished, <I>provided</I>, that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements
required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at
least as current as the date of those financial statements. Notwithstanding the foregoing, with respect to registration statements on
Form F-3, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of
the Act or Rule 3-19 of this chapter if such financial statements and information are contained in periodic reports filed with or furnished
to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated
by reference in the Form F-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(5) That, for the purpose
of determining liability under the Securities Act to any purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Registrant is relying on Rule 430B:</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. <I>Provided, however,</I> that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(6) That, for the purpose
of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities
the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration
statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to
such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will
be considered to offer or sell such securities to such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) The undersigned registrant hereby undertakes
that, for purposes of determining any liability under the&nbsp;Securities Act of 1933, each filing of the registrant&rsquo;s annual report
pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&rsquo;s
annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c) Insofar as indemnification for liabilities
arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to
the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a
director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by
such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion
of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the Securities Act of 1933, as amended, and will be governed by the
final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_015"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirement
of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the city of Yokne&rsquo;am Illit, the state of Israel on October 27, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Wearable Devices Ltd.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned officers and
directors of Wearable Devices Ltd. hereby severally constitute and appoint Asher Dahan and Alon Mualem, and each of them singly, with
full power of substitution, our true and lawful attorney-in-fact and agent to take any actions to enable the Company to comply with the
Securities Act, and any rules, regulations and requirements of the SEC, in connection with this registration statement on Form F-3, including
the power and authority to sign for us in our names in the capacities indicated below any and all further amendments to this registration
statement and any other registration statement filed pursuant to the provisions of Rule 462 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, this registration statement has been signed by each of the following persons in the capacities and on the
dates indicated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Asher Dahan</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief&nbsp;Executive&nbsp;Officer,&nbsp;Chairman&nbsp;of&nbsp;Board&nbsp;of&nbsp;Directors</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 27, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Alon Mualem</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 27, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon Mualem</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and Accounting Officer)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Eli Bachar</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 27, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eli Bachar</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Yaacov Goldman</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 27, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yaacov Goldman</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ilana Lurie</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 27, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ilana Lurie</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Guy Wagner</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 27, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guy Wagner</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE
UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Securities
Act of 1933, as amended, the undersigned duly authorized representative in the United States of Wearable Devices Ltd., has signed this
registration statement on October 27, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mudra Wearable, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 28; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
















































































</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea026255801ex5-1_wearable.htm
<DESCRIPTION>OPINION OF SULLIVAN & WORCESTER TEL AVIV (HAR-EVEN & CO.), ISRAELI COUNSEL TO WEARABLE DEVICES LTD
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%">&nbsp;<IMG SRC="ex5-1_001.jpg" ALT=""></TD>
  <TD STYLE="width: 34%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black"><B>Sullivan &amp;
                         Worcester Tel Aviv</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">28 HaArba&rsquo;a St. HaArba&rsquo;a Towers<BR>
 North Tower, 35th Floor</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Tel-Aviv, Israel</P></TD>
  <TD STYLE="text-align: right; width: 33%"><P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+972-747580480</P>

<P STYLE="text-align: right; margin: 0pt 0">sullivanlaw.com</P></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">October 27, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">To:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Wearable Devices Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">5 Hatnufa Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Yokne&rsquo;am Illit, 2066736 Israel&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Re:&nbsp;<B><U>Registration
Statement on Form&nbsp;F-3</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are acting as Israeli
counsel to Wearable Devices Ltd., a company organized under the laws of the State of Israel (the &ldquo;<B>Company</B>&rdquo;), in connection
with the filing of a Registration Statement on Form F-3 (the &ldquo;<B>Registration Statement</B>&rdquo;) filed with the Securities and
Exchange Commission (&ldquo;<B>SEC</B>&rdquo;) pursuant to Rule 415 promulgated under the Securities Act of 1933, as amended (the &ldquo;<B>Securities
Act</B>&rdquo;), for the offer and resale by the selling shareholder identified in the Registration Statement (the &ldquo;<B>Selling Shareholder</B>&rdquo;)
of up to 3,322,000 ordinary shares of the Company, no par value per share (the &ldquo;<B>Ordinary Shares</B>&rdquo;), that are issuable
upon the exercise of 3,322,000 warrants issued in a private placement pursuant to a certain inducement letter (the &ldquo;<B>Inducement
Agreement</B>&rdquo;), dated August 6, 2025 (the &ldquo;<B>New Warrants</B>&rdquo; and the Ordinary Shares underlying the New Warrants,
the &ldquo;<B>New Warrant Shares</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion letter is rendered
pursuant to Items 601(b)(5) and (b)(23) of Regulation S-K promulgated under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection herewith, we
have examined the originals or copies, certified or otherwise identified to our satisfaction, of (i) the Registration Statement, to which
this opinion is attached as an exhibit, (ii) a copy of the amended and restated articles of association of the Company (the &ldquo;<B>Articles</B>&rdquo;);
(iii) resolutions of the board of directors of the Company (the &ldquo;<B>Board</B>&rdquo;) and the general meeting of the Company&rsquo;s
shareholders which have heretofore been approved and which relate to the Registration Statement and the actions to be taken in connection
with the entry into the Inducement Agreement and the issuance of the New Warrants and the potential issuance of the New Warrant Shares;
and (iv) such other corporate records, agreements, documents and other instruments, and such certificates or comparable documents of public
officials and of officers and representatives of the Company, as we have deemed relevant and necessary as a basis for the opinions hereafter
set forth. We have also made inquiries of such officers and representatives as we have deemed relevant and necessary as a basis for the
opinions hereafter set forth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In our examination of the
foregoing documents, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals,
the conformity to original documents of all documents submitted to us as copies, the authenticity of the originals of such latter documents
and the legal competence of all signatories to such documents. Other than our examination of the documents indicated above, we have made
no other examination in connection with this opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have further assumed that
at the time of issuance and to the extent any such issuance would exceed the maximum share capital of the Company currently authorized,
the number of Ordinary Shares that the Company is authorized to issue shall have been increased in accordance with the Articles such that
a sufficient number of Ordinary Shares are authorized and available for issuance under the Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon and subject to
the foregoing, we are of the opinion that the New Warrant Shares, when issued and sold by the Company and delivered by the Company against
receipt of the exercise price therefor, in accordance with the terms of the applicable New Warrants, will be validly issued, fully paid
and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are members of the Israel
Bar, and we express no opinion as to any matter relating to the laws of any jurisdiction other than the laws of the State of Israel and
have not, for the purpose of giving this opinion, made any investigation of the laws of any other jurisdiction than the State of Israel.
This opinion set forth herein is made as of the date hereof and subject to, and may be limited by, future changes in the factual matters
set forth herein, and we undertake no duty to advise you of the same. This opinion expressed herein is based upon the law in effect (and
published or otherwise generally available) on the date hereof, and we assume no obligation to revise or supplement this opinion, should
such law be changed by legislative action, judicial decision or otherwise. In rendering our opinion, we have not considered, and hereby
disclaim any opinion as to, the application or impact of any laws, cases, decisions, rules or regulations of any other jurisdiction, court
or administrative agency. This opinion is expressly limited to the matters set forth above, and we render no opinion, whether by implication
or otherwise, as to any other matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion is rendered to
you in connection with the filing of the Registration Statement. This opinion may not be relied upon for any other purpose, or furnished
to, quoted or relied upon by any other person, firm or corporation for any purpose, without our prior written consent, except that (A)
this opinion may be furnished or quoted to judicial or regulatory authorities having jurisdiction over you, and (B) this opinion may be
relied upon by purchasers and holders of the securities covered by the Registration Statement currently entitled to rely on it pursuant
to applicable provisions of federal securities law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the filing
of this opinion as Exhibit 5.1 to the Registration Statement and to the reference to this firm under the caption &ldquo;Legal Matters&rdquo;
in the Registration Statement. In giving such consent, we do not admit that we are in the category of persons whose consent is required
under Section 7 of the Securities Act or the rules and regulations of the SEC promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Sullivan &amp; Worcester Tel-Aviv (Har-Even &amp; Co.)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Sullivan &amp; Worcester Tel-Aviv (Har-Even &amp; Co.)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea026255801ex23-1_wearable.htm
<DESCRIPTION>CONSENT OF ZIV HAFT, CERTIFIED PUBLIC ACCOUNTANTS, ISR., BDO MEMBER FIRM, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="ex23-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>Consent of Independent Registered
Public Accounting Firm</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Wearable Devices Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We hereby consent to the incorporation
by reference in this Registration Statement on Form F-3 of our report dated March 19, 2025, relating to the consolidated financial statements
of Wearable Devices Ltd. as of December 31, 2024 and 2023 and for each of the years in the three-year period ended December 31, 2024 appearing
in the Company&rsquo;s Annual Report on Form 20-F.&nbsp;Our report contains an explanatory paragraph regarding the Company&rsquo;s ability
to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">We also consent to the reference to
us under the heading &ldquo;Experts&quot; in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">/s/ Ziv Haft</TD>
  <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Ziv Haft</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Certified Public Accountants (Isr.)</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>BDO Member Firm</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">October 27, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Tel Aviv, Israel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex23-1_002.jpg" ALT="" STYLE="width: 650px; height: 74px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea026255801ex-fee_wearable.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FE.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.3a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ba2dbe2982a73c81d6403c1d416aceef -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">F-3</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001887673</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_004"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_005">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-26</xbrli:startDate>
          <xbrli:endDate>2025-10-26</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-26</xbrli:startDate>
          <xbrli:endDate>2025-10-26</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_007">F-3</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_008">WEARABLE DEVICES LTD.</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_009">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_010">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_011">Ordinary Shares</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_012">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_013">3,322,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">2.62</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">8,703,640.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_017">1,201.97</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_018">8,703,640.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_019">1,201.97</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_020">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_021">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_022">1,201.97</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="fee_023">The ordinary shares, no par value per share (&#8220;Ordinary Shares&#8221;), of Wearable Devices Ltd. (the &#8220;Company&#8221;) being registered hereunder are being registered for sale by the selling shareholder named in the prospectus to which this Registration Statement on Form F-3 relates. In accordance with Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the Ordinary Shares registered hereby also include an indeterminate number of additional Ordinary Shares as may from time to time become issuable as a result of share splits, share dividends, recapitalizations or other similar transactions. The amount registered represents 3,322,000 Ordinary Shares underlying ordinary warrants which were issued by the Company to the selling shareholder pursuant to an Inducement Offer Letter Agreement, dated as of August 6, 2025, by and between the Company and the selling shareholder. The proposed maximum offering price per share is estimated solely for purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act and is based on the average of the high ($2.73) and low ($2.50) sales prices of the Company&#8217;s Ordinary Shares as reported on the Nasdaq Capital Market on October 22, 2025. The Company will not receive any proceeds from the sale of Ordinary Shares by the selling shareholder.</ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !O +D# 2(  A$! Q$!_\0
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MHXKRW1(I&VAD/*_6N\!R 1T(K2K1G2=IF-#$TZZ;IL=11161TA1110 4444
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/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  _ )L# 2(  A$! Q$!_\0
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M5L0_?D](]EW?G;H>Q457LDNDM$%[*DEP1ERBX4'T'M5BN-Z&(4444@"BBB@
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MGV7R#;+*?-CW'))']*FN?$&H>+/@;<:G?JC74DVTB%,#"R@#BN(^._\ R/\
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M'T-8T/P!U4Z,[2ZE:C4F==B_-Y:)SG)QR>GM0 SX#_Z[Q-_UYI_[/7F?A_\
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,"E<$]Q@]*W* /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  N ' # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZQ_:._:>\
M4_"/XA'0M'L=+N+06,5SONXW+[F+ CY6 Q\HKZ&\(ZO<^(_!>C:I+Y<5Y?6$
M-PVU245WC#' SG&3TS7PU^V__P EJ;_L%0?^A25]L_"W_DF?A/\ [!5K_P"B
MEKRL-5G/$U82>BV/TG/\NPF&R'+L31IJ,ZB?,^KT6Y^?OB'_ (*.?%7PYXDU
M319=$\+S7&GWDUF[1V\Y#M&Y0D#S>Y%4W_X*5_%A%+-X9\/JH&26LKD ?^1*
M\?T-TC_;!M6D95C7QR2S.0% ^W'.<]J_7+6_&/A/1=,N+O5=9T>SL8U)EENK
MF)4"XYSD_I7ZSF'U++_9Q6%4W)7WM_F?SO@/KF.]I)XEQ47;N?*'[.?_  40
M@^(_BRP\+^.-'M="OM1D6"RU.PD8VSRMPL;JQ)0L> V2,D XKZ!_:7^(7B'X
M4_!O7/%WAJ/3YK_2O*F>'4D=HY(BZHX&UE(;Y@1SV]Z_+G5](M/B[^U+=VGP
MXLBNG:IX@$FG);Q&-8XA("\P7^!!AG[8'ITK]*OVT_\ DUOX@]_]!3_T='7G
M9C@<-0QF&]E&RG:\7TU7]?(]#+\9B*^$Q'M)7<+VDNNC/C2+_@IE\4YR1%X>
M\.2D<D1VMPQ'Y2U9L?\ @IY\1;&]4:GX6\/3Q=3 JSP.1[$NV/R-6?\ @ETB
MO\4/&@90P_L:/@C/_+<5]_>-_A?X3^)&DS:;XE\/V&L6DJE2+B!2Z^ZO]Y3[
MJ0:ZLPK9;@<4\-/"II6U3UU\O^"<N HYAC<,L1'$M-WT:[?UV/*?V=OVRO!W
M[0$W]E1I)X>\5*A<Z1>N&\X ?,T,@P),=2,!@.<8YKWZOQR_:+^$]_\ LN?'
M(6>A7]S%#"8]6T._+?OD3<=H)'5D964GN ,]<5]U_%[]IFYM?V+[3XAZ4_V/
M6_$-G#96[1_\L+J7*2LONFR4CW45YN/RB'-1JX)WA5:2OT;_ *_ ]' YK/EJ
MT\8K3IZNW5$7[0G[?7A3X/ZK=>'] LSXN\26Y*7"Q3>7:6KCJKR8)9AW51QT
M)!XKYQ_X>#?''Q"9+[1O#>F'3T.?]$T>XN(U'H9-Y_I7+_L*?L\Z=\<?B'J.
MI>)(3>^'- 1)I[9R2+NXD)\M'/4KA69AWP >":_573]/M=*LX;2RMH;.TA7;
M'!;QA(T7L%48 %=6+>7Y1)894?:S6[;_ $_KYG-A?K^:Q>(=7V<'LDCX)^&'
M_!3Z9M0BL_B%X7B@MBVR34M$+;HCW+P.22/7:V?8U]U>%_%&D^-- LM;T/4(
M-4TF]C$MO=V[;DD4_P CV(/(((-?+G[>'[-.A^,_AOJWCO2-/AL?%>B1&[GF
MMHPGVZW7F19 /O,JY96Z_+CH:\:_X)E_%F\T_P 9ZQ\/;JX>32]0MGU*QB8Y
M$-Q&0) OH'0Y/NGN:QQ&#PF.P4L=@X\CC\4=_N-</B\5@L9'!8N7,I?#+_,W
M/VW_ /DM3?\ 8*@_]"DK[9^%O_),_"?_ &"K7_T4M?$W[;__ "6IO^P5!_Z%
M)7VS\+?^29^$_P#L%6O_ **6OS;"?[W6/Z&XF_Y)O*O1_DC\=M=\+_\ ";_M
M&:IX=^T_8_[6\5SV/VC9O\KS+MDW;<C.,YQFOJF^_P""5=V(6-I\1('F'W1<
M:20N?J)3BO*O#?PLNM)^,^L_%'Q;?0^#_ NB^*KB]34-01C+J4D5VS"&TA'S
M2L2N-P^4<\G&*^O6_P""C?P9"$B_UECU"C2Y,G\Z_9\PQF.3IQRZ[26ME=7[
M7L?R]@,)@FJDL?9-O2[MIZ7/C:^/Q6_8#^(<=M'-ILD6H)YR2K;K-;:C"K ,
MN]E$B8.,J",9!YXK[%^-GQ1L?C/^P?XE\7V$1MHM1TM&DMF;<8)5N$62,GOA
ME(SW&#7QC^V)^TQ:?M)>+=$70]+NK/1-(22*U%TH^T7,DK+N8HI.!\J@+DGK
MZX'U#<_"_6/AS_P3AU;P[J-G,-=N++[5+8JA:5))[I'6+:.2P#*"/7(K#&T[
MPPF(Q,5&NYQOYJ_7\/0VP52T\3A\-)RHJ+MY.W3\3RK_ ();_P#)4?&G_8&C
M_P#1XK])J_-W]F2[T3]B[5=0UOXI:RNEZ[KUC'!#X8LH6NKVUAW;Q+<A.(B>
M $///X5['XT_X*8?#C2=)E?PWIVL>(-3*GRH9;?[+"&[;W8Y ^BFO*S?"8C'
MXZ57"P<HNR32TV[[?,]/*L50P."C3Q$U&2O==?NW/$_^"H>HVUQ\6?"5G&RM
M=6VC,\P'50\S; ?^^6-4_B7HM]%_P3A^&D[[C$FM&X8'M'(]T$/TY'YBO*/#
M7A;QY^VI\;KN[=6ENK^99-1U!4(MM-MAP ">@51A5SEC^)K]0/'WP(T/QC\"
MKGX91*+/2UTZ.RLI<9-N\0'DR>Y#*I/KSZUZF*Q%/*Z>$PLW>4&G+RW_ ,]/
M0\W#8>>9U,5B8*T9IJ/GM_D?,'_!*_4;<^'OB%8;U%VMY:SE.YC,;*#],J:^
M[:_';X?^,/''[%'QMF.I:4T=W"IM=0TV9BL6H6Q;.Z-\8(R R.,X/!'45]Z>
M'O\ @H5\&M8T=;N\UJ]T6Z" O8WEA*TJMCD QJRM]0:\O.\MQ%7$O%8>+G"=
MFFM>GD>EDV84*6&6&KR4)PNK/3J>M_'?5+71O@KX[O+UE2VCT.\W%NAS"P _
M$D#\:_,W_@GK93W'[3_AUX@2MM8WDDI'9?)*\_\  F6NO_:]_;<C^->C'P9X
M,M;NS\,RRJUY>72[)[\J04C5 253< >>6(' '7WK_@GW^S7J7POT._\ &WB>
MS>QU[6H5@M+&9<26MIG<2X_A=V"G;U 5<\D@==&E+*<JK?6=)U=$NNUO^"<U
M6JLTS.E]7UC3U;Z=SB_VS-,O-:^/4-AI]K-?7USIEO'#;6Z%Y)&+28  KZZ\
M%^+=!\+^#M"T?5M>TJPU.PL+>VNK6>^B5X9%C4,K#=P00:P?BS\*_$GBK4I[
MWPAJ.E>&M1O+9;:\UF6%Y+YHE)Q%$PXB7DY*\G/:O '_ &!/$4CL[^*]+=V)
M+,UM(23W))/-?D_+5P]:<Z<>;F\TC^EHULNSO*L+A,;B/8JBK*T92DWLV[*R
M7;5M];;'H?Q,^ ?P4^,'B5]<\5^,)=4O"-L2-XD58;=/[D48;:B^P'/?-<H/
MV+_V:PP)UI3['Q(/_BJQO^& ?$'_ $-.D_\ @+)_C1_PP#X@_P"AITG_ ,!9
M/\:]:&=YK3BH0NDNBD>#/@_A*I)RGC;M_P#3J1Z]\-O@_P#L_P#PHOXM0\/)
MX;CU2+F._O-22YG0^JM(YVGW7%>FZMXY\(ZKIMS9_P#"9:;9^?&4\^UU*%)8
M\_Q(V3AAV..*^5/^& ?$'_0TZ3_X"R?XT?\ # /B#_H:=)_\!9/\:Y*F88ZM
M+GJ0N_.5SII\,<,4H\E/,&EY4I(WK[]CS]G34[V>\O?$<MY>7#F2:XN/%'F2
M2N>K,Q;))]34VE_L??LT:;=I/)>VE^%.?)N_$1:,_4*XS7-_\, ^(/\ H:=)
M_P# 63_&C_A@'Q!_T-.D_P#@+)_C7;_;N;VM=_\ @1R?ZF\(WO\ 7/\ RD_\
MCZ<\(ZI\,O 6CQ:3X<U+PSHNFQ\K;65U!&F?4X;D^YYK;_X65X1_Z&G1?_!A
M%_\ %5\D?\, ^(,_\C3I/_@+)_C1_P , ^(/^AITG_P%D_QKSI8O%R?-*G=^
MIZ"X=X<BK1S%I?\ 7J1]&?$&T^$?Q6TH:=XMNO#.N6J\Q_:;R'?$?5'#!E/^
MZ17@=]^Q-^SA=W32Q>)I;*,G/D0>(HB@^F_<?UK/_P"& ?$'_0TZ3_X"R?XT
M?\, ^(/^AITG_P !9/\ &NNAF^9X9<M%.*\I')6X2X4Q#YJN.N_^O4CU?X7_
M  5^ 'PBO(K_ $)] DU6(Y34=1U..ZG0^JEV(0^Z@5[5I?C3P_K=V+73M<TV
M_N2I80VMW'(Y ZG:"37Q]_PP#X@_Z&G2?_ 63_&O0O@1^R=JWPB^(D'B2\UR
MPOX(K:6 PV\#HY+@ ')..U9O'8S$U4Z\;WZN5S'$</</8+"5)8/&MRBFU'V;
(2;[7Z>I__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex23-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "#!(8# 2(  A$! Q$!_\0
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MAG]*YF7)PRX4'>2>$QUW'.%'H2<'!P>*//7W88+9C!?* #+!5R[ $J,*I)+
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MYV9%1' .XHP8_P @WQV\4?$+XN?\$G_&&KVNK?#_ .&^B:3_ ,%7]>^'>O\
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MH>I>&-)\67G@*YTU8O%5KX:U>234_#[ZO9:I:O>Z+>+!/IM_%=6C6MMY7DH
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MCU/2/M$?@#PWID$=MHL>KVD2ZM'K%S!<?Z58W4ITT _=_6_CU\(?#GQ;\%?
M?7/'NA:7\8/B-X;U_P 7^!_A_=2SC7O$_AKPL\,?B#6-*2.%[2>TTN2X@2Y/
MVI9 \JJB,<@>KK.C 'J&.$/"ASS\J[V7+Y5U*<.A4[U4%2?Y:/B!\;/BM^UY
M^WG_ ,$H_C5^SS=^#?AG\1OC-^Q'\===&J_$?PWK7B/1O D4WB+PY:^+[NU\
M*)=Z1<Z[JVF:E9R1:!8:I=6UC<&)?M%X8D,A]I\/?\%1OVD/@K^R9^VUKOQO
MC\#?%[X^?LG_ +4Z?LH^%O&.BZ!)X-\'_$'Q%XDU;0M \+^*?$OAO2KI(M'L
M;&ZO=2U34+.PFCENK%+2U\VQE/VF[ /Z+FG5>3\H+;09 44D,%(#-A<[C@*2
M&?#,@91NI//QUPI&,AB,KG(^;#': PV[B0C$@HS*0Q_%'6/CE^VY^S=^T/\
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MX8^%]?'P<M9_@G/J_B^SU&QU=X[/XAS^)P=2L[:Z\2VAOO"4MX][IK;?)CA
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MU@N0"S(R@#:6=F8X5%C"L)#(5VLNS!=HU=TA174L5!X"EF Z'<0N[Y2694!
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M+QM:>+/^$H\23FQL]0N-1T*RBTC2$O+F*TBM)8-]T_=R_P#!1W]IS]D;6?\
M@HI\.?VH]?\  '[0'B#]DOP'\'_B%\-?%O@SP._PQT_Q#?\ QY>VTKPEX&\0
M^';'5-56WT?1]=\0^'+2?4[>YDU)+(7=U<ZA('C\H _HC,\:YR3D8&T#<V6#
M;1M7)RQ5E4?Q,"HR00#[1'@MD;5#EFW)M"HRJ[%BP&U2QSW!1U(WKM/X>VW[
M2_[;'[,'Q0_8I3]J3XA_#'XT> _VX/&EK\,[_P .>"/AVGP_U#X$_$37O#$O
MBKP_8^&=?LM6O#XU\)%8KO2]3O?$,8UJXDL3=6P*7*PV_P O>+_VW?\ @I#X
MI^&G[?\ \;/AK\4/@7X)\"?L'?'[QUX7'AG6/A)-KWBOXK^&?!=GHNLW?AZ^
MUJ?6+?0_#-G'H&MVJ:5K5AH]YK%QK5K);7UXEJ%F@ /Z8C-RP"ME<_*1\QVL
M02J@Y8;0'7 RZGY S!E5?]8N<@?>QW!&.&&"<@C!&#T.#A@5'XD?M!_ME>.M
M;\"_!#Q7\.OVQOA_^S;XL^(_[.7@KXX_\*?M/V=_$?[2_P 3]2U'Q3H^G>(;
M5M0T'PQ_;&KZ!\.YOM;:+<:P-'AN9)H)C;ZM'%"Q@^N/^"8_[6/BG]M#]C_P
M%\</'.F:/I7C6\UOQOX.\51Z!;7%GHE[K?@+Q9JOA*[U?2[&[DFN]/LM6&EI
MJ$6FW1%UIXN/L=PBS0.M)W5K63OUVV?ZV$]GUNFK+=IIII>=F['TY\>OC%X?
M_9]^$?CGXQ>*[/4M2\._#_P]/KVJ66CQ13:G=6]M(BR1V45Q-:P27!\Y1$D]
MU:QL=P>>/AJ]$\'^(K?Q;X8T#Q-:QR0VOB#1]/UFUBFP)8K;4;2&[ACF"Y59
M4CF59%4NH8':[#D_%G_!342#]A;]I5CM./AEJX"AF7+B:U.2RG. IX '7 Z<
MCZC^!R;?@]\,<'(_X0/PJ,D88D:+9#+<G)XQG/3 Z#)\^.*K2S>M@Y./L899
MAL3%JUGB*F*KTJR3750A!M6MJK/H?;5,ARVGX<9?Q-3A56:8GC/&Y#.4I/V?
M]G83AO"9E2CRO3VRQ6(FYRW<.57?3U6N?\2^*?#?@[2Y]=\6^(-"\+Z%:[!=
M:UXCU?3]$TJU:66."%;C4-3N;6UB:::6.*$-(#)*ZQKEW16Z"OQC_P""^T<4
MO_!,?XZ)-@1OJ'P]W$N1]SQMI&W WH Q=UB0*5=I9XI V+?:?1/BC]E([E)$
MCDCS*DVTQO$-\;(_W) ZDJ8G4-(LJDQL@R&+,BO@^'O&7A7Q?IK:SX1\2:!X
MITA+J[T]]3\.ZQIVMZ>FHV$KV]]I[WFFW5S;)?6=Q&UM=6CRK/!<*8941P0/
MYP;?QQ^W?X0\+P?\$DH(/%NI_$;Q3IY3X<_MKW%JZZ-8_L83Z9<-XA\4:SK&
M+N:+XS>%8(4^&]A9FW3[?>WMGK$%S_H,-S>> ?\ !/W]HGQ]^RS_ ,$_?@+^
MS_\  &/P])\:?VD?V]OVA_@!\.?%WCJPNM1\.>$[7P[\0]6D\6_$+Q!IMG('
MU[6=,T&S?4--T:6[6UU?69)S<W/E2-#$ ?UNB;&-ZLA)P-VU1P54GE^@=@@Q
MG><&,.A#'RCXL?'CX1_ RT\(7_Q;\>:%X"L_'WC?PY\-_!MQX@EFMH_$7CKQ
M;>)8>'/#&G%(9/,U35KN6."SA<()96\M6,@9!^4EC^W+\:/V1OC=\>_V?/VP
MO%WAOXUVGPL_9)UC]L?PA\7_  /X)3X=ZSK7A70-:U+1M=\"^)O!NDZGJNE6
ME]:WVFW*:#J&F1"*>P\J?4;.XF?)_-']KCQ-^V_\;/A7_P $_/VF_P!H3XI?
M"S1_A5\7_P!M+]ECQ)X0_9K^'WP[\O4?A_'K?Q#TS4?#&L:C\9+OQ!<:MK^J
M6^BRJ-4T5](M+66]NE>UGLA:M H!_3CJ?[37[/VBZ1X^U[5OC-\-=.T7X5^(
MH?"/Q(U.[\7Z)#:>"?%%S=V]E;:!XDD>]']F:K<W5U#!#97 6=YBT.P3(\:^
MT6NH6E[:6U]:W$%S9WL44]G=6\T4EO=V\\0FM[BVG5S%/#<0LLL,D;LKHP(Q
MA@O\HWQI^/?B?2OV9/\ @L?XC@\#? >:]^'O_!0SP=\/M-M]0^!OP[O=)\3Z
M&?BYX!\.?;?B)I-QI26?C_Q1:6%S=M9>*?$<<NL6UXL=['=SND9'VCXD_:1_
M;N^)_P"U?^T9^R5^SA\2O@M\%_#_ ,$OV;?@U\7]&\6>*_A3)XXUBQNO$GAV
MZ>?PSH6C6^LZ/X?-A?W^FR175]KL-_'I5I<1C2K!Y(%0 '[X>:OHV"H8$C"G
M<5"#<2 &8M@*2#P2< J3XI\1_P!I3X#?"3P7X_\ B)\1/BSX%\,>#/A5-;VW
MQ*URZU^QO(/ US=>4;:U\3PZ7-?7>D7<R31216=Y;QW4D;JZ0E64GYV_X)J?
MM.^,?VO_ -CGX5?'/X@Z;IFF>.]9G\8>'/&":+$]OHUYXC\ ^,O$'@75-3TJ
MV<.UK9:I=Z$;R"WRYA64KMB41Q)_.!^T1;6\/[.__!QCMCA3=^TM\/6N LFP
MEAX9\,_O99(IE 86YD,R$2))"@40Q2;7E /ZZ8?C-\+[CQ?X>^'\/CSPN_CK
MQ9X4D\<^&O!PU>S'B;6_"$>#_P )#I^B&8:A/IC*=ZW"V^ H82!'5D'?V>J:
M?J"3/97MI>+;74ME</:7,%RD%U XCFMIGADD2.XA9E$L#L)HBRK(BOE1^%'B
MOQ+X[UG_ (*0?LV?!WP-=_#OP9K?B+_@F7K?B?PM\6=1^$/@SQE\1O OC&Y\
M3W^EP7NE^)?$=K/JK^&&M+2-[SP@U^NC7MREP;ILW,BCD/\ @@SX8^-@^&OQ
MW\6>*?CK<>*O <'[4?[1'AF^^'MWX)T*SN;_ .(6G>+;$:W\06\:))+KMC;^
M(I2TEMX-C$6BZ%$L-KIF^W8,0#^A53N .." 1R#D$9R"I((_'Z<8-1RDC!'8
M@MC[VTY^[[\''(]N:<@ W<YRW.2I(.U1@E0,D8Q\Q9N.6(QADJ[AG) &#\I(
M8[0YQD=L'@=\G/8T>NSNGY)QE^ME\PNULTGLK[7;2U^5_G8\'^&7QW\,_%#X
M@_&#X>:+I^IVFJ?!WQ%I_ASQ!=WB0)97U]J.F0:K$^F.ES+/-#';SHL[W-O9
ME9?EC6929%]\7IUS_P#6 'X=,_CGJ:_-;]CY0?VG_P!NX@L73XL>%URQR-K^
M"=-?J,?W3UY' R<\?I2HVCZDG\Z\S*\34Q6$A4G=M8G&T]=_9TL16HTVO[K]
MFTO-/3J?8\=Y)@.'N(999EJG'"QRO(,7RU&Y3^L9ED&3YCBFF]X/$8VLX[6C
MRZ*PZBBBO3/C@J*2:.(,9#L1$:221L)''$H8M(\CE4VKM^8*69=RLRA#NJ6L
MG6%)T_426*(-/N S _,<I)AE&X<P@%A&<K<%_*;ID 'F]C\?O@=JFM6WAS2_
MC'\*]1\0W=\=+M=!L_B%X0N-9N=5$S0'3+;38M::[N;\2I(GV2WAEFW12+MW
M; W#^,_VQ?V8/A]H'BCQ1XO^.GPVT?0?!7C[2?A;XNU%O$EC>Q>&OB)KMVEA
MI'@_7(M.DN[C2M;U"]EBM+:UOH8#)<.(0WF*ZK_--_P1Q^$^F:IXBTKQR?\
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M.E:?X7\"^./'NOZC=111W$L%GX:\#>'O$7B"X>*&5)IA'IC>3%YDDI189C&
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MQY\3]$\*^%]+\._#&[G:XU3PIX9\%>#+.ST;28M>D\D>([R&4SZY':6:7>#
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M+\03CP1XLX.1X>UDXXR0-.N3VS65?^!7_P"O-;_TS5/0RC_D;Y3_ -C3+?\
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M</0:U3C&2?1ITTD_O/F<U_Y&F:+K_:F9/Y?VACU?[]!S@ D[MN5VGYGQU)&
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M<')ZTFK[=U^:%UCYRLO-M227S^X^$_\ @IQ_R8I^TK_V376/_0K2OJ'X'_\
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M:EI>IP66K:1KVD:C9WMAJNB:K8V>JZ7>6MS:W]I;S1E#YKJ7[5/P&TGX@?\
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M-\1#6O%\'B_4=/TG0+NU\,)H[>)+&PNM0U33[:XO]6TFPM-,DNX?[4GLPV0
M?5=%0QS*ZAL'G!QQD94-S@D=^""0PPRED968H XGXBOX\B\+:P_POM/"%_X_
M%M WARS\>7VM:=X1FN4O(A(^O7GAO2]7UV&T@@DEDA-AIUZ[79@1HK:-I;ZW
M_&GX3> OC/XP^ O[3NA_M*GX=?##X7VG[4/Q\^(<7CCX?1_%+Q#X^\-_%?PS
M^T,_C?0?$^F>#O$W@FWTOQ3\-+#Q3I::M8Q37-P_BKPZEC936,2M=7$_[ER
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MK4^"KKX@_ ![H^,[W3/A]<:9I?CY[&VL7\.Z+9SWFG7<5IXC?^UQ';16E_\
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M!W!%! /PG_9^'QN^$/CGP+\/='\=_&"_^,FH_M4?$R7XZ_ [Q+X+TYOA)<_
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MCO4_"5FMUK<.EWOBC3]:\1R7,-A/J&EZ#\0(=>O-)LTEN1;_ +=F)MI 8!B
M ?F & P&U5($>-Q5"N64*C,TA&*! %)(XR3DCY3U#@D %&*R;G'RJ S.2"9)
M2X!\3?L'Z#XCLOA[\6/&.L:-K7AO0_BY^TC\;/BU\//#_B"U.G:M9_#OQEXG
M$_A>]O=)F O='D\006L_B9--U#%[#%K4<DR0K*D$7U9\0&5?!7BP<@CP[K&?
ME9@ ^GW('"AB<'E@ 0!R<"NR0$ !B">,D @9P-Q )) )R<%F.3RQJCJ&GP:C
M;W%K<QI-;W4#VTT,BJR20RHT<T;@J<QRHVR09.5X '.Z*D>>$X/:<*D&^RG3
MJ1OWWDMM=3IP->.&QV Q,TY4\-CL)B*D8V4I4\/B:%>:BWHI-4+1;TNU?2Y\
M&?\ !,4EOV,/A)D$ 6VN%#D%6 \1:L#M92R.I(ZJS*2-IPRL!]I^,7\8Q^&-
M=?X?0^&[OQN+"9O"UMXRN]6L?"LFLB.7[*FOWFA66IZO:Z8[96YGL-/N;A%V
M^7%*WRAG@3P!X0^&7AC3?!G@/P]I?A;POI(F&G:)I%N+73[,7$TES/Y$"Y">
M;<2RS/AN7D)/<UUQCSD$#:WW@"5SR"#D#/'S<;@.<$')(YLOP[P>!PN%DW)T
M:%*G?31PA9KOO^MSUN*\WH\0\39[GM&A/#TLUS;'YA1H2:YJ-/%UO:*G4Y6X
MMKHTVNJ9^#_P[\"?&[Q=\./VS=(_:-_X5G\+?A6G[5/CKXCZMX\\"M\5==\>
M>&?B5X+\0?"KQ;X+\3>$O"VN> K2Q\:_#"P\2Z+H=W<Q7$HO=6L8M3L([>/:
M1;=-X+\7?'?PQ;?MF?M4VWB+7OC%J.O?";X._!OX,Z]8_!K5_A+8?$CQQH5]
M\0,>)/#GPYOM6\3ZW_PC7AV_^)&BP2:YK5^UQJ.HZ3XGMT^RZ=#9V</[<&)O
ME(8$J/E+#B-MCJSJ!B1C(6._,RG&"&R#N=Y9^4 \*P9=Q+8P#R<_,[$L<EW/
MS8D!S\H[#P#\K?C5\44_8D^&O[-_[.WA?Q-+X/U+QY'K%KXU_: USP/XK\<:
M5X4M_#]E:>(?B#XRU#2O#NDZK)J_Q+^(WB+5KS_A$=,U=K/2DO;W6-0U.:*W
MTRTM[SV/]G.UUW2O#7PNL?V8I/A9XL_91F36KSQ!XU\;:G\2-+^-'B+Q;J'B
MC7[KQWXCMO#\G@;3]#N;_6?%4MWJ=[=:I)HRWM[=WUU:V\5I):R3?=A@R0>.
M&8XRXQOWAV0JRM'(0[%7!+)YCJ"5*[7^7P!@$$_,.%R,\#Y4'^K 58^<E1AB
M3EB ?CU\0M1M?B1^V!\%M;^%OQ+^+GQCU_P-\=KN7QM\$?B!X.DTSX0_!;PD
MO@_7- \1_$'0M<@\ ^$;JUU[1G2U7PK<W_BSQXNH3>)=2LQI^R5WM>C_ &L?
M"?[47BOP)\,-:^+;>%/"?AWX<_M->!?'WBS4_P!F>+Q!\1O$^F_#?2M+\36%
MGXOGT/XA>!EM'U_P5XPU?PEXN=[+PUXK2PL]#OM:M])O&M$LH/U@,.&+J%!.
M6( ";Y 25+LJY(4EB-_FC+EBI902T0N#P4QE@, J!&<L%92'$A)PKEB'.^:5
M)(_,\D 'Y2_#[XLZT_PE^-,_Q$_:#^->F? JT\>>%]*^ O[49\&:+!\8/$FF
MZMHL5YXB:YT]?A+J/AN[T31?$D5WH^D^+W^&>GPZE:W%U!?H5MK>>;Y,?P%X
MITCX0^![J[U/XM>'?A9X8_;K\>?$#P_^V'I?@RZ3]H/1_ASXO\!^)M;\1_&3
M6O"<NAW<!D^(/Q(US6OAAK?BF;X?OHC>#-;M]>G\$6AN88$_H.\GEBH1"W5T
M5=[?>"YWJPW0_(8]QDC."/*0!-IY!!RK#.]FR2YP0'$>59F\P(7.5)7^#8R+
M%&@ /YW-,\ >-M/T7X)^/-<\2?&;PW\%O!G[3?[2&MZU^TGX8\(0Q_%KQ]I?
MQ)^'.B:;\/OVAO%WA#7?"?B^VL[Z^UZXU[P1-XFL_A^RZ;I>FZ=XAT_PMH<6
MI"]M?JZR\2?'3XP_!/X0_ _QM+XNUZP^.G[1'COPA<_$F^\+R>'_ !+XH_8W
M^&^HZYXKMO%GCRUL+#3['P_X@^+/A70_#WP^O;A-/T6?5;/QK-K]CH=I>71C
MMOUV\A=ROA=R_P 14EB &"9)8[F3.$=PQ52X _>$AHA8EMX3#>6#AG8XC#,A
M4-A8WCD*E&10"RF7"LP5 #\*?VW/"^IGXT?'BUA\1_$SX&RZG^S=X3^'OP?T
M_P"$_@BY\0Z%^UG,T/B6XU'X7^/9+?1M4L[.U\,WCIX'TNQTF_\  6L6&C>-
MKZ_M_%5O;RRVQ\T^.WP]U*3Q+\4O#_B^^^)_[+4OCO\ 9B^!WACPO\*OA-X$
MO?'G@#]ICQ'HOP[\C6?A_P"/(WL-76^N?!-U:_\ "GUT?2-<^'VJ2^ HX;O4
M/%D]I?(]K_1%Y3@H4*)M9BV 22K,69 3DAI#M,DIW$E6(7,A96FW&  %4*@0
M*O$:J5$9VQLK(OE("(5P8_GD#1Y=G(!Q'PJNO$EY\-?A[>^,O#MCX0\7WG@C
MPK<^*O"FF3-<Z?X8\23Z'82:WX>LKE_FN+30]2-SI=O.3F2&T1]J9\M/BG_@
MJVX7]ACXT@Y \CP66.,@ _$;P>@R>V68#&,D9QTK]%$0+N. "SLQ()8GLI)(
M!SM"_* %081<JH8\9\0OAUX*^*WA34_ WQ#\,Z/XP\(ZT+5=6\/:]9Q7^EWX
MLKVWU&T-S:S*\<AM;^SM;N L/DFA1QRH(Y\71>(PU>BG;VM*I3_\#A*/_MU_
MD>_PKFU#(>)<@SO$T:F(PV4YO@,PKT*32JUJ6%Q$*U2G3;<4ISC%QBW))-W;
M5A? 3B7P9X4<AD;^P-*)5AM(S90!@5ZAE/!! Y!P, $]->/+#;W,EM";J>.%
MV@MTFCMY)I0&\NW2:8&*)[F39"LLFR*,L7>2,+FBSL8K"VMK*UBB@M;2*.V@
MAC4*D=O"BI%$B@ *BJH"J  ,#C  JUL.[<3DC)'. IYZ87<0^0'!8C"+A<Y)
MTI0]E3A27PTZ<(Q\WK=?(\?&8CZUC<7B8Q<(8G&XW$0A+XJ=&OBL17I0FUHY
MI55S--IO5'XU^%_BI^TE\3OVF/VNOA5XP^!_COP/X0\3_!_X*^&O$5[+\=_A
MOJ^G_ '2?%.B?''2KSXE:1H]IX@,%[=>(K9!J=Y:^')6UF,^&;!M;B,2Z4J>
M?_ 5/$&D?M&_L[:!)XH_9J\6_#O]F_\ 9L^+?A[XD>/?@#J6L:Y9ZK\.8M'\
M(:5X/O?B[J%]I\'ABQ\0:UKGA;Q!X@3PA:ZEXFET>:+Q3J<][;PZA'<W7[AK
MHNFI<75XEA8)>7\%K:ZA=I9PK<7]M8K.ME;WDX47%S;VGVFY$$$\TB(EQ<Q@
M;;B05E:-X(\)>'+"]TKP[X7\-:!IFIM-)J>G:-H6FZ7IVHRW2^7=RWUA86]M
M;7DMU%NCEDNDFW1LT;JZ-('T,#\Q_ GQ(\!_"/\ 93^)?[>?QC\)Z3?ZY\>)
MM+^(0T2:QT/29'\&WNKVVB_LX?",76LB/3-%M]/T:]T-KZ[U*9+"T\6>(/%'
MB:]87-WY5;OP$OO%G@BS\8?$GX:>&OA[^U#\0?CQ\1+7Q#\<-.^!7Q?^'&E?
M#CX-FS\/:9I'AO0;!-6UCRM=FM?#MJAU/6?LNFZMXFU"VFU*73+47MM OZ0Z
MMX0\,:]HK^&==\-^'];\-2PVUM)X?U?1[#4M&-O9>6;.'^RKZWN=.:&T:"!K
M:W:U\N%HHW7#Q@FCX5^'O@;P+;W=IX(\%^$?!UKJ%REWJ5MX5\-:)X>@U*YC
MA2V2YOXM(T^TANK@6\4,:RR1&1(X8X5?RU& #XU\4V>E?';]L31OA[?Z9IT_
M@W]F3PCX3^-'C>SDL]/N_P"U_C9XYNM8L?A#;ZC,+=A,WPYT'0/%/C&&!MS1
M>(-9\&ZQ%#ML5\[YU^/VIZ1XL_:F_9H;PM\4?A-\5O#NE?M,6E_-\"?AIX:T
M;3_BOX%\7Z;X4\9:=JOQ.\;?$?2/%&LZC+X>\.W:W \3^'M6\+>#;?7%U"PM
M)->U0:=!:7_ZZPZ596UQ=W=M:6EO>7[0O?7D<"+<WLEM&(;>2[F0)/=O!"HB
M@>ZGF:"(>1%MB)%8>D^ O!6@ZMJ.OZ%X/\+:+KVL%SJ^MZ3H&DZ?JVJ&1O,=
MM2U&VLDN[YY)5CEE>YED:25%=V;8H(!\F_$']H;QYX%^ 7QJ^*_Q=_9^N?AO
M/\.=&O+GP7X7U?QIX*^(!^(&L.ITOPW'91>#KBX.G27VN7.FZ>EK*(-0D6_7
MR)HHXU>OG#]HG]F/P-X$_P"";7QSTKXA>%_"'C7XCZ;\$_C#\3?%WB_5M!TR
M<WGQH\7>!-1N?&GC>R^WV[QZ<1,DFG:)=-']KTOPUI.F:<)T>QC#_J[>Z58Z
ME;_8]1LK*^LPUNXM;RTM;NV:2UFCGM9&M[B"2(26EQ#'<VKJH\B<+(B[HD)=
M>Z;::I97.FZG9VFH:=>P3VM[87L*W=E=VMQ%)#/:W=I.KP7EM/#*\-Q!<(\,
MZ%O-C;>54 _G[_X*4P?'/Q7^RUK%I=_!36_%/[.'@3]GSX?>*=(\2^'?BEX&
M\-6^L_%&6UT(QZ[XV\)W^IV'B2[\/>"8GL[?PUH=G;WBZMKE[=Z[?$VVD:,4
M^@?C/XDUGX(_%OQ#^TWX:\7_  UO_B=\3?#G[.G@7QS^Q5XETGPSXP^*ET="
MU_5=+5?"'C'PCXIOM1L]1L[+QSJ>HE$\(WOA2\G\-Q37&NV4 +1?KU>:'INH
M:?-I%_IVF7^D3P?99M*O;&WN=,GME4".UEL9XY+=K="%"1.LD<2)LB0(X2/,
M/@;P@WB*+Q?)X4\,3>+8;6.QB\5R:%II\316<<0@%M%KS6SZI%;I'Y@6".Z2
M+;(4"I\SN ?E=^V7J.E^(_B#\,=*\._$_P"$OC.PL_VCO@"/&/[-'A/PMIDO
MQYU[Q3H_Q(T*X?Q&?B7I?B>^UKPK#X)CMXO&>N0ZEX-TJVUKPKX4U3PW_P )
M78P:P;>;P/XUWNC66@_MP^#O$"6:_M6^+?VP?AQJ?P%TQ[28?$3Q'H4+_"%?
MA7K?P]W^9K-QX4\-6MOX\&K76DW,FEZ G_"51ZC<V,=]]GN_W)M? 7@NS\17
M'B^U\'^%+3Q;>*8[OQ5:^'M(@\1W4)5XS%/K<5DFJ31O$[QLLUW*=LT@#8&'
MN7?AK0;K6M/\27>@Z)=>)-*L[JQTSQ#/IMG)KFFV5YN%U96.LR6[ZG96MVK/
M]J6TN84DD'F/%)O9 ;B;2W[I:)O5NRV3?]:GX9>-;SPU;_ O]LCX<^(KGP^/
MVRO$'[5_BS4_ASI-[9K)\0M5\5ZG\4=%N?V=O$W@^TGCE\17/A/3O##^')+'
M6=*>?1_#FB6.HB^_L]5O[-OW>LA/]GMVN&5YVBC,^QMZ><R*TP1P%W*)2XW
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MAV/P%J6C^!O#-Y>:GXEU^+Q3;OIDVO?$0^)M/D379K^UNEADU/H_@KKNE/\
MM/>*/C+X0^*WQF^/OPOM/V>?'6E>//BS\3O!,UGKGP<U"T\6^'-6\/> OA@N
MF_#[P2-2/B&%-?UKQ1X?C\'ZIJ4C^$_"6IWNL7R.D%Y^Q*VY7/.3D8+,S':J
MJ$+L3YLDB@%0\DS'),@*@K$BO"S8SL;"[>> 0&RNX.)58H2&1F#,KH<$+-(
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M" 00O-4OV=/C#KOQF_9:^$7QPUO2]*TOQ+\0_A%X4^(6IZ3IC74VBZ7K.O\
MA^UU6ZT^PDN9DO);"*XN9;>U>:X=FB0/O(8"LGBJ,:SPTI)5>15;2E9^SE)0
MC)NS5G4O'>]UM9'T%+A/.J_#%#C"%##QR;$<5?ZFTL2L8W6>=/+*6;>RJ81T
MU..#>"JTY_7'[L:JJ4[-J[^E0^X@J5&#@[2&/<X#+G"D'//3KWJ=2,'MSW/?
M_/K^9K\]OV!?VL_$_P"U7\#/$WQ<^(.A>'O!MWH7Q6^)W@3R-!N+Q='&D>!]
M9DTVRO[ZXU>;?#<W$4,LEW(6CL(G0H)5)0R_8'@SXJ_#7XAG48_ 7Q"\%^-3
MI%S<6>J?\(IXGT77CIUY:S?9KFSO1IE[<?9+B&X'E20W'E21OA7"DJ#-+%TJ
M].,XSAR32=.=U&,XMRY6N9QTO&6NFSNEUO/^"^)N%\YS_)<VRC$_6N&<;# Y
MQB<!#&9EEF"KU</@\124\PH8*6$H4ZU+'X?V3KUZ#J5)N-.,FM/3/\_6HI#C
ML3\I/ SPO)&!\Q)R" !S@]\5Y7+\:?A+#XLA\!3?$[P%%XYG+B#P8_BW01XJ
MF$<ZVSM%H'V\ZHZB=UC)2U.)#Y9 E5T7?\6>.?!O@/2YO$'CCQ5X>\(:+ A:
M75_$VLZ5H>FQ!&>-1)?ZG-#;QF3SCM#2J>B/Y3/M;7VD$I-5*;<&[KVM/=*_
M*[5-';NU;0\V>2YPJN$PT\IS6%?,%&6!P]3+,QAB,?3E*-IX&A/ 1K8V$[I1
MJ82CBJ<N9.-26E^N9E# _*K%<D$_, 1D$J>< XSQD$\@#-/#$$!O7;SMR!M/
M\1.#NVDA5+-R"0 >/RR_8(_:L^(7[1WQ?_;6T#Q)XF\.^*_ GPC^-&E>&?A3
MJ'ARRM;>%/".H:1=WJ%M8LWDA\0&XN(XUCO5/V>5893!)+#Y4LWIO[6/[:<W
MP,\:_#GX(?"SX;:O\:?VC/BO'->>$OAYHU[#H^G:9X9LKDQWOBWQEXAF@N1H
M7ANS$,S&78\MS*'ACC.X&N6>84%AWB:C4**<>5W4W/GJSHPY?9^U;YJE.48Q
M7-*35TK'VV.\).-,OXWQ/ ']GX6OQ#A,%1S/%4J5:-'!Y=EE7(\MXEKX[-,5
MC7@Z674L#E^9T)9EB,9]7A@YTZM*I'VW)1J??V_!'7DDXW'C'!)_A7Z9!/3&
M00'*R[NCJ-F<D%02Q(R P'. <]P "1M(8_D@G[>'QY^!_P 0OAUX/_;<^ FA
M?#CPE\5O$D'A#PM\7_AGXP;QCX$TGQ7JUV\>C>'?&4>I:=IUYHTUPKVUM%?(
MEW8SZBTBV[$ NW4_\% OV^9?V5+KX5_#WX;GX7:Q\:/B[KW]FZ9'\4_&,/A3
MP+X&\/1PAY?&/Q%U'3R^K:'H%W,8K2QU&:S6SNY+6\MX9A<6_ES1_:F$=*M5
MFY4GAY4X5:=12ISBZ[C&C>,E%OGYX<CLTW*ZDO>Y>_#^"?B#C^(L@X9RO X3
M.,3Q71S'%9%F669IALSX=QF&R:G7JYMC*.<Y?A\53^KY3'#UEF"K82%;#3]E
M3EAIU*^'CB/U&63G^'C@$8)R>%R02.5(;'7!4D#-1LXB9CF5L9)4,"=H8JS!
M>#L4]< XP!W%?A)\8O\ @IY\7?"'B?X%_ [P'K/[&NK?&[QOX&E\9?$KQYXB
M^+M]9?LY^#[M([:YTWPUI/BB!'UA[_Q1:7]M=: -5@L[N]LKBSE2S9+BW=_N
MWX>_M&_%KQ#^UGK?P%\0^$_AK%X$T#X+>$?',GCC0/B+HU_XHNO&&L?9&U#2
MO^$"DN3XFL/"S+/<_P!E:GJ%F@NXH(9A,8[M1'5#,J%9R4$FXU5AY+F5E5<>
M94WJVI63YDEH]+O6UY[X'\>\/Y9A,XSG!Y70PV+R3-.),)AYX_%T<;B,AR7%
M+!8K-*&&JY1AINAC*[Y<M]K5IU<2H2E4PF!4Z/M_O$,KD!%^8@-EP1D$ @=L
M'G&" 1CUXJPIX/'0XP/7 SW]??I7E=M\8/A;/XI_X02+XE^!I_'(VK)X/M_%
M.B2>(E)*)Y@T);Y]3",Q49$#XWJ<A,[)=8^+_P +?#WB73O!^O\ Q)\$Z'XO
MUHRC1O"VL^*=$TSQ#JOD1+-*NG:+>WL&HW31Q2++(L5LQ6-EE8",[ZZW6I.+
M;J4X\DE"3=6FTIM-J/,JG)S<NO+S<R_EZ'YO#(,]]I"FLBSJ-2IA/[2I47D6
M;0Q-3 25_K*H_P!FNM4PM*/O2QL*4\+RVE+%)--^HTQG"G!!X4L2!G !  *@
MER6R=N%.=K#(. :]O/&ZGRRS_-DG:PP"2@8 C.TE"5/1AAE)5E)<[AR!AAGY
M0&!*MGAB57YCM!5MVX(,@[@:::DN:+37=--?>FSSVFG9II]GH][;;[Z;?J3%
M^#A'8@-@  %BO\(+E5RW\)+!?4BG AAD=,D?7!(S]#C(/<8-?EA^QO\ \%&M
M)_:I_:F_:P_9Z7PW8Z%I/P;U07/P7\5P/?A/C#X$T;6=0\#>/?%-JLYDL[JU
M\/\ Q TV/38;O39I5D@O56X2VN[>[MX_T.\2?%#X:>#;7Q#?>,/B'X'\*67A
M*UMK[Q3=^)/%FA:);>&[&]\S[%>:]+J5];1Z+:7?DRBSFOVMXKA8F:-W.ZF(
M]"HZUY#K'QY^"/AWP_X<\6:_\8_A;H?A7QDUI'X1\2ZQX_\ "NF>'O%+W\D<
M%BGA[6[W58=,UEKR>:*WM!IUU<&XF8QQ;V# =WJ_BKPYX;T*?Q+X@\0Z%H?A
MNUM$OKGQ#K.KZ?IFAV]G(@D2[GU>]N;?3X;9T(9+B6X6%U8,CE02 #HBP7KG
MMT!/4XZ#)_'&!W-(K!P2I! 9ER""-RG:PX)P58%&!P0RD8Z$^4Z3\:_@]XE\
M%ZM\2_#WQ9^&NM_#K0+*XOM?\>Z/XZ\-:IX,T33;*%KN\U#4_%&GZI/H>F6M
MM8B6[GO;O488;>-4DG**C8^7/V-O^"AGP!_;,C\:67@;Q3X9T7QCX5^)WQ(\
M!V/P]U/QYX5U+QWXG\/?#O58M)3XF:1X7L-3GUA_!'B2.2*_T;5H[2:SN;)X
M[UKA6N)(X@#[Y+ ''H,D\ *,]3DCW/?@'VR@D4@GGCZ'.?NX()4[P04&<G<
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M?@7]I+]K;Q9X(_:M_P""<'@3X9>+_!>I_!K]IWQC\<],^)&KPII6OV.M>'O
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M6B3:WV/>&5?,OV;?CWXB^)'A77M1^+[_  =\'>)#\:OB?\./!FF> ?BGX?\
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MJ;E&#<'6P=1Q?(KJ2;46VE^C .1G!')&",'@D9QZ'J/4$'B@L%ZYZ9SC@ $
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M0>K_ &-$JY(!!4J&# C!+%0@/(SYA;Y&&5)R"P/%31,NTX+%<C!*G'*AL@@
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M$$@D'K@X)'0@]>A%+7FDOQ7^&MAXLM_ =YX_\&VOC6[$DMKX1N/$FD0>);B
M2%4EBT26\34YD.4C#+;'>?\ 5[D1F'H1N4(."<@C.""!ERAR<X ###9(8'J
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M=#T2YU/3M*OKJP@UO6+AEM](TJ>ZMXEU'4+MXH[&S,]Q(089%7\KOC)^V?\
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MP7.C))]CN;J:.27R+V0&:W8Q[<A>:5K^R?\ ""U^.OQ!_:*_X1^]O/B/\3O
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MOX3?"^T\)_$G4=!NP!%>VFC^)HY;)M7M3-;ZB;WSXKB0#;'[EXD_X)$_L/\
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M4+A]1.FR:<UFUU'!OB>)-M 'P-\7?BQXW_:<_;G_ &/]5A_95\/?'WP%K?\
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MV:66EZ3I>G01VECIUA86_EQ6MC9VL,<4-O$VW'7;L&X _)'_ ((;:KI>D_\
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M^T_\!?VT?VB?VCOAQX+^+_[4>L_$W]H_0/'UO\5=!T'QKK?PB/@:?7],\">
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M.#Q9KWC+4-7U+6(;;2[V\MXX[V6?8UP7A:'RXU3EOA/_ ,$ROV1O@[X\\/\
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M(WVCZQH]S;2Q3VSI,\$T4L/DW0::"X$SERG _P#!*[X9_"K31^VUXUTSX9^
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MSPEXD^)_C_Q?\3;[P%H][')!=:3X#'B[4]0@\*V-Q;,D$T6F0QR-; V:SK"
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MVO;J,AI+>)+;]1/@C_P3C_9@_9^\5+XL^'OAWQNTMAINMZ)X;\->+OBAX_\
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M<5O)%>SG_)+:^SV[GJHD4X/(!Q]Y2A!8A5!5@K98G ^7&002",4JMN4-@KD
MX;&1D9((!."#E2,\$'ZGY+^!7Q^UWXI_&_\ :W^%FJZ!HVF:9^SU\0_ G@_P
M[J>F7-U-?^(;7Q;\-M \<7VH:U!<!X;2\M]0U::QMD@E:&2WM(9F"2,V/K 3
M1C)W#;\S,^0$!5@AY)'5B<D9565][ XRTTU=;$M..C5O7S)J*\CO_C[\$-*^
M(FG_  BU+XN?#:P^*>JLB:?\.;OQMX;M_'%U)- EU;QQ^%9=277!)=6[K-:1
MO8J]U&=UN) 5S!XP_:'^!'P^U*YT;QY\8OAGX,UFSNM%LKO1_%7C?PWX>U:V
MN_$<:RZ!;RZ9J^I6=\)]95XQIL"P--=EU$,;@,53E%;M+6WS[#4)NUHR=]M'
MKZ'L)8 XYSC/ SU( SZ9)X)XX.2,4*ZO]T@CU!!'0$<@D<JP8?[)!.*JB<74
M8:W965HQ)&Y DC+CRY(FC*,$G0[L%XYS'N7:K$A]OS7\*?VF_"GC^#]H/4M<
MLH/AUX>_9[^+OC'X5>(_$7B?7;"#1+A/!FFZ1J%YXJDOYS:V6A:.]OJ81XKV
M<+;M;&5[AGNUBC;DD[-I-JZ7EW!1DTVDWRM)VZ-NROUWT/I\'/\ GI[&EKQS
M1_VA?@7X@\$I\2="^+WPWUCX?/K%KX?7QKIOC3PY>>%AKU]?P:59Z/)KL&I2
M:9#J-UJ5S;V<%K-<QR2331*H*R(S0ZQ^T?\ L_\ A[P78?$?7/C9\*M)^'^J
MZC<:1I/C74/'_A6T\+ZMJUK=O8W&EZ5K<^JI8:GJ$-W%+;R6EC/<3)+%(C(&
M1@$IQ>JD@<)K>,E\G_P3VFF&11D<DC.0H+' [X&3@G@<=?8$CSO6?C#\*?#O
M@!/BOKWQ'\$:1\,9;.RU&+XA7_B?1K?P9-8ZG)%%IMW!XE>\&D7%MJ,T\,%A
M/!=R17D\L<%L\DLD:-X)^T/^TWI?P^^ VD?&SX57'@CXJZ/KOQ$^%'A#2[^T
M\0P:IX6O].\?_$WP]X!U:_LM8\/W%U!=7>E6^LWLT,,<SQC4+-+:Y\LI,%::
M>S3%ROL^VSW/KXRH" >IR0.-Q *JQ"YW_(SJK#;D,P&.:>"#T/3KZ@X!P1U!
MP0<'G!%>4R^.KZ/XMP_#EK/P\=.D\ S>,CJ;^+K,^)VO8O$0TL6"?#_R!?+H
M45G*TW_"4_;V@N-29--2U+V,\PW/'?Q,^'OPJ\.7'BWXG>./"GP]\+VDMO;7
M7B/QKXBTGPSH4%W=D+:V+:OK=W8V/VR[DS'8V9N#=WSAH[2*>1'1&VEOH'*[
MI6=WLNYW=%>=>%OB]\*_&_@J7XD^#OB/X&\4_#RWBU&XNO'6@>*]"U;PA9V^
MCK(^K3WGB.ROYM(M(=+6*1M1>XO(Q9*I:Y\H#-97@OX]?!3XCZ#XA\4_#WXK
M_#SQUX;\)_:#XHU[P?XP\/\ B32/#R6MK+?32ZSJ.C:A>6FFQ"QAEO4DNY8D
MFM8WFA,BHV%S+NA\DFVE&5UNK/2^USU@,#ZCZXY^G/;O]12YZ?7'T.,\U\D_
M$_\ ;;_9G^%WP=\=?''4?BOX0\3>!OAVE@-=N? _B7PUXDNWU+6+6VO=%T.Q
M$&M0V$VM:Q974%WI^GSZA:R30/O9DP0/2-)_:)^!VK>"_"_Q$@^+'P^3P3XR
MN9K3PWXIN_%V@66@ZQJ%O:W%Y=Z;8ZM=:A#I]SJ%E!87QO;6&X>2TDL[F"X\
MN>/RR<T>Z^\;IU$KN$DN]F>WT5YOX9^,7PJ\9^"KSXD^$?B-X)\3_#W3X]4F
MO_&^@^*-%U7PI8PZ)YG]LR7NO65[-IMHFE"&5]0:YN8Q:QHTDQ5!NJCX5^.O
MP8\=>$-9^('@GXJ_#_Q=X'\.F_'B#Q;X:\6Z'K?A[0VTR W.H+J^K:;?7-CI
MK6=N/.N%O)H6BC^=P%R0<T>Z^]?I<7++^67W/_(]6IK.%QG/)P/0L3@+]6[=
MN#DCC/BY_:/^  \)^(?'@^-/PM;P3X2U&ST?Q/XMC\=^&)/#>@ZO?V=GJ%EI
M.IZVFIMIMMJEU9:CI]S;Z<UR;R>&^M'B@=;B(MY+\6/VK_"GA2R_9U\7>!?$
M7P]\9_#3XR_%JW\":M\0(/%FG77A32/#O]C^);O4]>L/$>F7=QHLEQI>K^'O
M[+N5N;V."TO$NK6Z>&>"1$3G%:MK^OD"A)Z<K^YK\TC[ \V/Y?FQOQMW?+NS
MC&W?MW$D@ #)RPXP<T\$,,CGDCL>0<$<=P00?<&OG#Q+^T+X$;X*^*/C1\*?
M%GPR^)GA[PU%<Q1ZG!\3_#.D^ Y]1TO4K?3-4T[5/'\)UW2-#O-(65RT3[Y[
MB]6"S"I]H25>D\;_ +0GP0^$<>A0_%OXM_#3X::AXDM8;S2K#QGXZ\,Z#<ZE
M'(L<4UQIHU.]T^75;&&Z)MVU6VMVM&<Q[Y4,BK24X-V4DV/DFM>5_P##'ME,
M9PO4'DH.!G[[A!GGCE@3GJ,[<X(%6SU&QU"UM[VPNH+VTNX8KFTN;6:*>WNK
M:>-)H+FWGB=H9;>>&1)H)T<Q3PNDT+O$Z.W#?%'Q=/X%\!>,_&]C;:+?W/A/
MPGK?B"V@\1^)K+P9X=GGTRQN+F*WU?Q;J$$]CH6GS;':[U>YCE@TN&$SS*J2
M'?3:2N]B-VH]7LNK/100<XSP<<@@'(!R#T88(Y4D9R,Y! 6O!=3_ &B/A#\/
M_ W@7QA\8?B9\+?A5!XZT?1+_39/$_Q'\+V.A7^H:EHUAJ-S:>'O$NIWVF6'
MBBRMC<A8=:T]5M+VW:VN@L:W,8/MUMJ%I>6\%W:3QW5M=6T=Y:W%K)'<PW-M
M+&LL4T$UNTD4L4L4D<D,L;M%/'(DD#R(P:BZ>SZ7^7<J491MS)J^BNK7]"Y1
M7D6A_'[X'^*/'FI?"WPS\7OAKXC^).C"\.K> M"\;^&=6\7::=-<)J<=[X>L
M=3GU2WN-,R'U&TEMENK)&1KB&/>F[O/$7BSPWX0T/4/$WBK6]-\.>'-(M'O]
M6UW6KVWTW2-+LX]@>YO]0NI([6V@1G5'GDE$*2,L;R*\D:N*2:;3T6[[":<6
MDTTW:R:LW?:R\SH:*\(N_P!J/]FVQT?7O$-W\?/@U#H7A;54T+Q+K#_$WP5_
M9N@:Y*I>'1M8O!K9@T[59E#F*PNGBN7$<A$>$;'5^,_C-\)?AUX0M/B#X\^)
M7@;P?X$U#^S_ .SO&/B/Q5H>D>&M1&JPFYTTZ=K%[?0V6H"^MU-S:BSFG,]K
MF[C#6JO,LJI!IM232W>I3A-63A)7VNGKZ'IE(3SC!/\ GK^'?ZCN:\YU#XP?
M"G2?#GA_QCJ?Q(\#:?X2\630V_ACQ1>^*M#M?#WB&:YM;J^MX]%UF>^33M3,
MUE8WEW$;*YF$EO:SR(65#7))^TS^SI<VOA*]MOCQ\'YK?Q]J+:'X'F3XC>$B
MGBW67NOL*:;X>*ZJ6U:[-\GV,PV*SN+IHX-OFRQHXJD'HI+\?\A<LOY9?<_\
MCW R(O).!D#<<!,LQ51O)"DL^%"@EBS+Q@YIRMN&<$=,@XR,@-C()4XS@E21
MG.":^"O&7[:_@WX7?MB:E^SY\5O$GPQ^&?@'_A0N@?$_0/'/C7Q?:>$]0UOQ
M?J_CR[\)-X2L9-=O=.T:_@ATR(ZND5F;F^BF,\MP8[5(Y*^L/'?Q<^%OPL\,
MP>,OB1\0_!W@7PA=SV=M9>)O%GB/2]"T.[GU"$SV,%MJFJ7L-K<RW4*23PK#
M*QD@1Y54QH\E-2C*]FG;<'"2:3B[O;1Z^AZ/17F^J_&+X3:%X=\/>+]:^)?@
M/2?"?BTP#PQXHU+Q=H%CX<U_[3:3ZA =(UVZU"+2M0$VGVMU?P_9;N0S6=K<
MSQ!XX)"O2^&O%WAGQEX?TCQ9X2US2_$OAC7["/5=#U_0[VVU32-8TN9=]OJ6
MEW]E)-;:A87"%9(+JSDGAEC=)$<HP:CFCW0FFMTUZI_Y'0E@O7@<8/J3V ')
M([\=_KA#(H(7G)5FY&,*I4,3NQ@+O&?H0,D8KR:U^/'P5U'XB7GPBT[XL?#J
M\^*NG;_MWP[M?&/AZX\;6?DQPW%S'-X;BOY-7BN+>SN(;RXM6M!=6]I/#<SP
MQPRHY^47_;&U77/V\T_9&\%I\(V\.^#_  -#XI^)^K>(_B"EO\19]:UBTO[W
M1/#'PY\&V;S'6+[3K6"QU/Q9+J,MB-)T_5+*4"9)(G=>TAOS+=+KN]EL/DDG
M9Q:=G*S6MEK?T/T%$R$ @\%=P/ !!4/P20"-ISN!V=1NR" ><G7G[NXXPQVY
M 4A4+,ROG*L@9< ABI&*^9OVL?VAX/V6O@=XF^,\WA.[\??V'JOA/2+3PO8Z
MW;^'9]1OO%WBG1_"=BKZWJ,=U:6-LEYJ\4LUY):LOV9";>WN)?*AFYGX#?M0
M:G\5=2^-?@GQS\*-9^$OQ8^ NJ:9;^,_"%YXET?QAHMYIGB7PV/$WA'7?#/C
M;1+.WM=6T[6-,Q!<QWFDV&KZ3<1>5?:<)-PC'4@I*+DN9JZ76RUOL4J524>=
M1;C=*ZMNW9:7OOIM:Y]@^8N2,\A@N!@G)) !VDXR!GYL8!&<'("&5 ,D@<[>
MJXWYP$)SM#D\ $]>N,C/Y8^%O^"C/B=?!WPJ^,7QC_9?\4_"_P#9Z^+EQX7A
MT?XPZ7\0_"7Q$TWPI)XVOXM*\*WWQ&\+Z9I>DZUX6TB\OIK:*^U2PFU^UTB:
M^@%Y.(V+I]$?'G]JF\^&'Q#\#? WX5_"S6_C?\=OB!H.I^+[#P-I>NZ9X.\/
M^&/ .CWMK8:KXW\<^-]6BO-/T#2AJ=Y%INDVEG!JVKZI>R2)9:>T4$LP;G%;
MM?C_ ) J-5NR@[V;Z;+?6]M.NNA]D!U(R""/8@].#R"0<'(..A!%(9$'5@.
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M\/TN-'O_ !#"WC3Q=H'AE9=#TJ:PM]2U9#K-_9[]/L)]5TR*[NES# ]_:J[
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M_1_Y'KA4,3ABK!ER5"Y(0\##AP <XR #Z$'FG*NT$9)RS-RQ;J<X&<8 Z!0
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MXU%58Z?;+:?:+X+)]EBE\F;RSGCH[K5-KS2W#EE=JSNG9^3\SUW>N<9R1@D
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M==\<^,;#2I[R+PZMYJ\HTWP]X<GU6]O[6QBU"]ODLGU"..;U+]LGP+XN\?\
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MQ'X;@\4:;XITG1I-+N-.O[6.== MTO3:W:>KZS^SWXO\/_L#>.='^&/PU_:
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MOZG#%X?TV%[::VMM='A^\DL[>_%B'6QN)5D,S7,K+\_^(/V;_P!HW0OV9O\
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MGPH^(?C'X4>*OV4M;\*W6J?"C1?@GJGC";XRWEC-:W'A?XF>+/C-IFKS>%/
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MT;^U-1M=/;4]:NEGDL],T\75S;MJ.J74$,[1:?9L;J:**X,<4J1D#@)_B_\
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M\*_#C]DOXC>'KN]\5Z/I6N0>$O'^K7_PJAT_3G34XIIK;Q)+I>G>([=IX )
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M^+%A\&/V[?V<9?@SXA^%/C7Q9X[_ &HM0\ ?%:^L=#T_P5XQT7XK^(?$%YX
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M^/WA#XK:KK'AKX->#?A;X=\8Z]?Z+?Z?H_PATOX>V-GXFU'P?K4T%W=VNO\
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MM?V"36RW'DSZ>$T^<I-^W99&5F8N@&T?ZLH51MA)$BR%&55D):XB8K%YC*)
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MM_X3ATN[U&;26O/$^FWEQIEWH-KJ.I6FG:;>ZM!J-O<6JV5E?M<2W*,EN"6
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M'QEE+-@=<# >1,+)+\^P@F!$D+2DG2;7QK==7K^'F7#%.$N:,-;-+F6FMO\
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M4TR0W4 AFB+;HRBL$0A3G%._=:=]]33V\'+6.EI:WU3E9Z.W2VBVZ/0_-?\
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MY+2:0SO^[0^'/@86GV$>#?"2V8\2#QHEHOAS21:#QFMP+Q?%C6Z6L<3^(UO
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M4EP$BM_"I2!H+/1[:(+!'<23#;<,Q;Z$^'S?$+XG?\%&OVHO#VM?&KXEZ?\
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MS-NS5^ISS:E*Z7+JG9>7]?\ #GY'?#[PC<:9_P %+OVW?&.C>(?&FJ>(=&^
MWP5U?2_"L_B>_E\/:KJ&L:/XY-EIM[H*O%#?Z9I\VGPQ:!9%ECTJYN]2N(R\
M]_F'Y8_9T^.7CN_U+]AKXHZ;^TW\0?B?\>/VDOBGJ_A7]I7]GK6_&4&O>$O"
MWA^'P]XNU'QM+I/PPMXH;;X0Q_!S5=%T:QT^XLK'1+C6[;4E;6&UR:>,#]^X
M/#.BVNKZCXAM=(T:#Q!K$%C::OKD6F6T&K:M9:4TITFSU'4H52]NH-+$TOV!
M+B::"S>>YDMK>)IY-_,Z-\)?AIX=\5ZUX[T#X>> ]#\;>)X#!XG\8:/X1T'3
M/%'B&,N)C%K/B"QT^WU;58Y;C$\RZC=W2M(H.PEBPQ5*<6TI:-W;7>]^O;T-
MUB(OXH-M)).RMHFK=-'OL?$W[-&F^-_B)^T?^U3X^\6_&7XHZGH?P@_:"\2_
M#/X=?":/7+;3OAEH6DWGPN^'5_<7.H:-9V$>H>);LWFN7-]I\>O:G>6.A73&
M^T6SM)[VZ!_1H1D \ALLQRQYP6)4?* ,*I"Y(W'&69F)8Y6FZ!I&CW.JW>EZ
M5I>G7.NW\FK:U<6%A;64^KZJ8+6T34=4DMHD;4;];&SM;%K^[,ETUI9V=L7,
M-O$B;(SW]3^63C]*VC%K=M^73\=3GJ/FO96TM;[O0_('_@JKH&@3^(/V%?$?
MBCQ]XH^'_AW3/VO? ^E:WK6C>,KGP=I6DZ?JVC:^W_"0W>I))!;V&M:5<VL%
MOH>M3W"SZ:-1OX[1-]W(PY3XX?#*Y^+G_!27X;>$-#^-'Q.^'VD-_P $_O$=
MY+XG^%WB6PTSQ=XHTQ_C!9VUBC^-+FPU74;2VEN)K?5KG5M#%E>7\T"-=7S6
MRS!OU]\8^ _!GQ"TM="\>>$O#'C;0!=VU\VA>+M TGQ)I#7MFSO9WO\ 9VLV
M=]9B[M'=GM[A84FB8DI*,XI]OX+\+VVJ6NM0>&_#T&L:?HJ^&M/U:#1]/BU.
MP\.*R2_V#9WHM_.M-$$\4<T>C6S0Z='.K3B$R2-42@Y-]%>]_3YG13Q"I^R]
MSF:A.+>EE>WE>_EJF?@;J/[2_P <_&?["7_!.S6=5^)NN:8GQT\>_P#"#?&3
MXH:=\0)?A5K6KZ7H-CXYC\.VE[\8+.TU1O!UYXSU;PUHUGJOB/3;6WU+5[PW
M-O;S:?\ VA?1VOZI?L)W'Q7D^!*VOQ?^(7AKXG:]I7CGQMI6@^*/#OC*Q^(,
MP\%V>L.OAC1/%'C33K.QMO$OB[P]8.-&UW6/(:YU">S2ZOI[F^EN)Y/HR]^%
MWP[U+P>?A[J'@+P3?> VA>!_!%]X4T*\\'R1.\L[1-X8FL#HPB^U327#(EHH
MD=W9CO8L=WPMX3\,^"-$L_#7@_P[H'A3P]IRLMAH7AG2+'0M%L5D;S)5L]*T
MZ&"RM$>5G?RX(E4;N<G)*A"<9+5N-GU\B:E6$H-1@HMRYK]E=NWXV_JQN2-@
MC@$A2PY()(9.,J&(C!QYK$8 *X#'@?S1_P#!09KV_P#C-_P4>\,_\+L^"7PZ
M\.W_ ,!_V>+[Q/X#^).BV=SXS^+5KHV@^)-2'A3X?^(;C6H9O#^L^((+"?PY
MIMS8^%_%%RNL7]G+'%8R0-.O]+[+N^N/8$@'.TG#':W0X&<9QUKS/7/@S\)_
M$_BFV\;^)?A?\./$7C&R2".S\6:YX(\-:KXFMH;42):0V^O:AI=UJUJEFC*+
M?[/?(BEI-D46\EJJP=2*BG;WD[[;7%0JJE-RE'F7+*-M-W:SUTZ'Y;?&KXF^
M$8OVBO\ @E#\0_B1)IWPO\/ZQX.^/VMZA8_$C5+#2X?"]SJG[/NE7*:-K.HZ
MW)8V5OJUG<7$5A+=7#V]S-*ABA^2[D$>;\"G?XB?M)?\%%_B'^R-<Z4OPL\5
M?!_P9X3T/Q/X:"V?@CQC^U7I/A;Q>NH^*O"[64-KI&JM9Z?>>%-&\2>*]--Q
M;7NK6'RW<MP)IY_UI\9?"SX<?$:ULK3XA_#_ ,#>.K?396GTZ#QAX4T3Q-:Z
M?.0RF:RMM:LKV*UDD&WS3;B(R ;'9D5171:/X>TGP]I=EHF@:5I.B:-I]K]C
ML-'TFPM=.TNPMFD5OLMC864%M9VMHB@K]GAMXUE)R#"V]WATFFK/[+7,NNEM
M^_2QH\1%Q?N6;:]W=:2YKV?^?R/Q(^!OQ-_8K\*_\$O8?AW\1=2\!Z<^C?"7
M6_!WQI^%'B==(C^)VI_':XL+VT\:Z=J_@VXMXO%VL?$7Q!X]N+^;3M273+B[
MU:\U&SU6PGFM9$N4_2C]AW0?B-X9_9%_9S\/_%M;R/XB:1\(_!=GXIMM2+?V
ME9WT>C6QAL=35_GCU*RL6M+74(7+-!>0SP,<QXKUJ[^"'P>O_&4?Q'O_ (4_
M#.^^(L,RW-OX]O? ?ABZ\8P7,6P6UQ'XDDTS^V!/:Q0P00W*WJ7*Q0QJLR;1
M7ID431@ MDEG=NG!D=I"@(1 P7=M#LH=P/,DW2L[,4H2C=R?R_733R,ZM15%
M97CN[WO\OQ_JP3%@#@@<=6R57&?F()4$#.7 D5MJ\9)Q7\]5EXW^-FMZ5XU^
M/<_[3?Q>MKOX9_\ !3J\^"OA_P "P:_I4/PR3X:_\)WH_A74O"^M:%!IUM>>
M(HKS2]<E*C6M9OK?3);:&XTRP\XR7%Q_0PZ;OR*]<85B"QP0RL?E7 9<=>>:
MY&'P!X-@M+FPA\)^%H[&]\0OXKO+1- TQ;:Z\3R745])XEN;<6WD7'B!KR&.
MZ75I8S>1S*K^;(44UM)732=KD4YJ$;./-K'IV;OOWO\ @?AC^U3\4_VC/$?[
M6WQV^'WA7XS6WP2OOA+X6^#FM_ .#Q+\<++X/>"M5'B#3UU/Q1XO\0^%M1T6
M]LOC=IUSXA^W^#M3TN6]>+0;(06]S;V-W>VS7GK'[0.D^'H/^"HO['FL?$;X
MG^(/AY?>(?V;?BLD,%A\09?"WA^\\5Z%XH\ S/X9T"2Y:*WO+?Q&+JY_MC1U
MEDO-:LK*QC%NB"<K^L7BKX2?#+QYJ6BZSXZ^'7@+QGJ_AW<="U3Q7X0T'Q%J
M6B-([22C2;W5K"ZEL%>0K*5M?)4SQ).RM(L9BM>)OAIX#\:7.AWGC'P5X0\6
M77AF\DU'P[=^)O#>D>(+OP_J3*$74M$N-8L[R73;TJJF6YMW2XD8)F;;!$M8
M>SERM7U<D]>U]_EY6-Y5X.2M#EM!Q;7>R[WW:OK?UW;_ !3_ &J_BQ^UCX4^
M/?Q=_9)^#/CWQ9'\1/C!?>&?VD_@;XEU":6^M?"7PN\$^#=<OOBE\/K&Y:"Z
M2QTW4/B+X%T/0;+3D206^G?$=Y(V63$1U8?VL?C5\0OV,?VM_P!N#X=^+/$=
MAX6\::EX<TWX"V$MFDT7PP^&'AN/PUX0^('Q'T?2+VU9+G6H_$&I^-==U-+Z
MWOH!<^&+&)56S@:YD_;.;POH%QK%EXAFT31I=?T[3KG2+'6Y=+L9=8L=(O98
MY[W2[+5);=KNWT^XN(+6:6SB>.WE>UB:2,L RP:7X1\/Z%HJ>&="T'0=%\-0
MP75O#X>TO2+#3]#B@OYII;VVBTFUMHK&&UN7N+J>[@CB!O9KJ82R1KRTRP]2
M4E)57:S5KO?NQ+$04;.CK=:V6MF[_?I?R7F[_D_^S1XWO/"G[5>O_!OX5?M$
M_$#]ISX,:G^S#8?%CQMXI\<^/%^)DOPY^*%WXA>R\/&Q\:E7N](B^(OAZ:_U
MV3P,;\67A\:-%>V-MI-M>6T$_P \Z_9>--8_X(O?&WXW?$?XT_$KXO>-/BU^
MS*^NZG)\0?%%@?"&@KI\C+9V'AK1M/L=,T?0X;B.3_B<:Y<QWFL:G<)'+J&J
MAX;6&/\ <SP3\*_AO\-+*_TWX=?#WP/X"T[5+F6]U&P\&>%M"\+VFH7;@I]I
MU&WT33+&*_N)8CLEGNTFD"(D>9#NE;4D\#>$9?#!\$R>%?#$G@UK$Z8WA-]#
MTY_#3:;NWBP?0GMWTQ[$NL;/9&V^SNP=V1B^ U0FKOVE]&K7?7U)=>%X_NVK
M2BV[+97O]][:=#\X_P#@F+\2/%GQ&\ ^,[KXP_$'7+W]H;0M4T7P_P#$SX(Z
MBSZ'H?P-T_3-*@A\%Z+X-\*)=W0N_#/B7PU)9>(HO'UT;J]\6W=[//+<P);"
MQL?U#A(VA1G[H8<$ +@! %^ZN$"AE0! ^[ SFN<L?!GAG3-6O?$.G>'?#UAX
MAU.RL=-U+7K/1-/M]8O[#2@XTFSO-22#[==VFE++,FFVEQ<R6]DLT@MTC0[*
MZ2*,Q@#.3SN)())))ZJB A1A5^4850N.!6M*$HQ?-*[;V[>?7^D8U6IU).*L
MG)-/R[+T_7[_ ,8?^"G_ .T.OA;Q9IGP5\->,_B#X ^(:_ 7XB_&O2==TOX]
MV'P!\%RV?ANYETVU@?4K?2-=\5>/?%UKJMJE[9^"-&TV[T^^L56#78'L]05X
M^=/Q2^,_QP7_ ()-^%G^.OCKX>M^TS\"O&OBGXQZ]\-[G0-%UKQI?:3\$O"W
MC"X6VGGTJ^M-+NUU>ZO9X;_2;:/4-#EO97L+?3VEF"?L5XL^&7P\\=7^D:EX
MS\!^"_%U]H7VDZ-?>*/"^A:_>Z.UV$2Y.E7.KZ;>SV N$&;@6DL G,4*R!E!
MQ>M_ WA&UF\/W%MX4\+VTWA"UN++PD]OH6F0R>&;*\M4M+RQT.9;,MI%I=01
M1V\\>EK9I+;*L$L<B(%;-TI\S?.[-;7_ ,[G3"O"-/E<+O75V?1K\]?S/PAL
M?VB_C;H7["6JP2?&KQ98KX9_;E\1_LP^+?VC=6SXJ^(/P^_9^T_XJ:GH%_X]
MUK6IX+@OXGTW1+>RT-_%VHPE-.N;R+4Y SV,#M]'_P#!.S1?"GAW]I+_ (*$
M:-X&^(WB'XL^&+?QI^SV^F>//%'C\_%+5]:DN/@GI5[JD]]X[DN;M==DTS4K
MN2TBMC>-_8EK'!HUO%%:V-M&/U('P^\&1Z/J_AZ'PEX5BT#Q!-JEQK^AQ^']
M,ATC7)]<9IM;GU?3DMC9ZC<:Q<[)M1N+F!Y;ID4SM*5YK>!_AC\/OAGIUQHW
MPZ\">"_ 6CW<OGW6E^"_#&C>%K&YG"[1/<VNAV5C;7$_SS,TTD!E)<+OP"2U
M"2:;=]5II]_04ZT)4I04.5N2?XW_ .!Z,[9$9HQNVABA4C 9,M]\[<*&60@/
MAL'#')&<5^97Q<^'EGK/_!3+]G#7Y/%OCG3KBU_9Z^,>M0Z7H_B6YT[2'?PY
MXY^%4?V">PCB9)](UJ/59(?$%FKA;RVMK=+B6&-(V?\ 3I5VC!()SR<8SP ,
M\GG  SWQT%8]QH&D7.K6NO3:5I4NMV5K/86>L3:?:R:M:Z?=SP7%W86^I-%]
MNM[*YGMK:XGM(+B."XFMX7G238NW62;BTG:]OP9C3J>SES6YKIQLO[RM?Y'\
M\OBOX^_$A+;XV_&W4_VDOB3X0_:A^'?[8EK\'/AU^R?9^+;>W\#7/@<?$/PW
MX1\)^"]0^#45FO\ PE</CWX?:CJ7CQ?'MY:W%U"\CW%EK>FO:DU]XV2?$#XG
M_P#!0_XC>!]5^-'Q-\,_#SX/_"#]G[XD6/PO\&^(H](\.:UXNUK7O%\=W+XG
M407>MWNA7D>AFRU+1-.U.RT[61Y1UF2Z:S2.3[]NOA-\-[_QI9?$;4/A_P"!
M;_X@Z=;+9V'CN]\*:'=>,;"T11&MI9^)9["37(8#&9 JG472 ,5CC*NU=3!X
M=T:UU:]\06ND:5;Z_J=K966I:U%8VT>J:A9Z>938VE_J20K?WMKIYN+AK&VN
M+AHX&FD$8C5L+BZ4]/>>ZZ^?E9FLZM-WY86;3Z+2]M/3??7OUOKQCY&RH5B2
MS ;3AL X)55#;>%!(R55<DU^=_\ P4Q^)GC[X7_L]Z'J?@+Q%J'@U/$OQF^$
MO@?QYXSTS6&\,7?A7X<^*/$\=AXCU-/&8L]1C\"&[+6FA+XSGL+Z/P['K%QJ
MR6K7-E;S0?HF%PI7@<G '0>F. 1D_,02Q!)&XC%8VN:!IOB/2[[1-<TW2];T
M74[62SU'1M:L;?4])U"VFPLL%_8744MO>VKQEA-9W22V]P J.L>#)6TDVN5:
M/?G[6Z?,Q@U&I&;7-%-7B_S[>O4_&;3_ (V^.OV>/V-/VE?''QE^*^O>.?!W
MACX@6>E_"_Q+\+OC1X<^*?Q7\"^'?$$GAVPA\.^+/C#K6@_V3#)H.KW>ISW'
MBCQ)97U_9>%+MY+G43<FSDB\W_9^_:3^-7AGX)_\%'IO"7CV7XK:W\#-!T+Q
ME\&K>?XLI^T9/X;7Q1\+(?$]ZD'Q#N= TJ[\666B:C-<ZK%X?-KJ.EZ7-:W&
M@Z=J>I0EWC_;?2OA+\,]!\'W7P]T+X=> M'\ W\4\%_X)T[PEHECX4OHKG!N
M$OO#UI90:3?1W)&;N*ZM)%N\CS2"A,E[PU\./ W@RUFL_!_@WP?X2MKJWM[.
M\MO#'AC1M"MKJSM5E2WMI;?2[.TCDAA2:7R()Q/! )IHUB99'+8*C-2NZC:U
M[G1[>FW5_=+WI1:TTTL_/SVT_7\G;F/X9P?L+?M):QX3_:L\8_M+:MXH_95\
M2^,?%C>-?BI;>/+2R>^\#:I/<ZWIOAV1GD^'VE:K/<7C3>$;>6SM;.*./38[
M,S1S238O[*UE\0?A#\?_ -C_ ,%R_'KXI?$SPI\</V*]2\5>(?"?Q UW1K[P
MOI/B#P*/AM)X<U;P-X:TS3+'3/",5AI?B6]TA[31K:--4B2WEO[B2ZAGF;]8
M_#GP4^$/A"T\0:?X4^%?PV\,:?XL2>/Q38^'_ _AK1[/Q+'=)(EQ'XAMM/TR
MVBUJ.5975TOED22-S&ZE$4'JXO"'AR"]TC4H- T.'4M TFXT+1-1ATJS@OM'
MT>Z%H+G2])NXX?-TW3[DV%DTUG:>7;M]D@4QDQJXITI:>^WJM/F2J\%S+V?2
M23LNJTMML]N^S.@@(V\'<"2P;);=T&=S%F;G@9)V@; <**_./]O_ ,=^)M%\
M2?LK_#>7XC^)O@K\'/C%\6M8\,?&/XN^$=9'A76]#LM*\(W^N>#?!T7CADE/
M@BU^(7B*W.E77B&V6UO<6$>FV^J::+Z29OT>1"IR<<CG;D+GC[JDG:.,D \M
MENK&N;\7^#/"OCW1+SPUXT\->'_%WAR_15OO#_BC2-/U[1;\(Q>-;O3-4M;N
MRE\M\/&TD$FUN2C;%!TFFTHK?35=+>O<RIS49<SBTM=++JG9_KZGX'_%+Q7K
MGCW_ ()R?\%,/!=Y\6O%_P 5_AC\&/$?C'PA\(_C%K'B--3\0^+O#&BZ1X2U
MZ]\/:QXTB1(?'FG^'?$UWJG@^^U^Y?4)?$=C!-#-?3R*LQ_:[]G3PS#X1^"/
MPQT.#6?$6OPVW@OPY+%JGBG6)]=UB5+O1[.Z$,FHSA3);6OG&ULHHU$4%I%#
M"N2A)[*U^'/@C3_"!^'^G^#/!]GX#_L^73!X+MO#6DVWA(6,SF2>R;PU;6D6
MC-97$A\QK5+2**)RQ57#8'7VUM':006MO%#;V]M%'!#! BQPQ00HL4,442*D
M<4:1(BI'&BI&!M08 )F$)1=W*ZUTT_1%5:RJ1<%%QUNG9=K?B[O?J,N?FWQ;
MVC\V%@71F20*-P8I(GSQ%0QVR9!5V4H&(8#\;_V"M'\$^'?BA_P4(T6/XJ^*
M==\=:)^T;\5K74OAYXA^(EWJMS%X;N]'\/WFG^*=2\)S3M-+=7\+?9[3Q T'
MEQ62#3[9K=O-DE_9>2,2<$*RXP4<;D8;E8Y7'+87Y6)(0X.UJX>T^&'P]T_Q
M3JGCFP\"^#+/QMKEN+/6O&=KX8T2V\6:Q9[((VMM5U^"P34=0AVP1@074\L.
MQ!'L7>ST5(N3C;2U]2:<E"-FKN\=?1OO?O\ @?A9^R);_$#X51?\$M=1M?CY
M\3_%7AW]H#PQX_\ #?BSX=:UJ^B'X9IX9TSX7:AXO\):=X?\'Z;I,=I8W?AK
M5+2V;^WY'E\2:@D]S;ZKJ MIVM]/3X>?$_\ :>^)7[5?C#Q!;_&:Q\%^)_ 7
M[8>N?#77/A9XY^.%OI?A.Y^!>GQ1V5GX6T3]GR?0PFI^(?$>E7,'B'0O']EJ
MCZE>:A'NN=06S@A6#]X;3P'X1LT\/QV_A;PQ;+X2CNHO"BVN@Z; GA>.\M9K
M&Y7PZ([97T47=C.]I>#3I+83V[20D!)&SDWWPC^&.J>,K7XC:I\.O 6H_$.R
MBAM[/QY>>#_#\_C.S@MPZP0VOBB;3Y=<@AMHY)(K.**^06D4LB1-EBS1[*>G
MO=>__ -76BY)\OV6KV778]#C^Z#@@D#)/WCA0,MP"6P,$^PP2,&OCK_@H!Y:
M_L4?M2F:18HE^!_Q"\UV\@1@?\(_?;!,+A6AEC<AHEBF5H2TA$J,&5D^Q8U9
M5PQ4G)Y4%01_",$L<JN%R6)(4'C.!FZIH^G:Y87NDZU8V.K:1J5I/9:AI6IV
MD&H:=?VMP-EQ:W]A>)-9WMM/'F.6"X@=&0NIW"0@:M-TY1ZN+2?GV7>^WW'/
M!N,U/5I33Y?*^_JM_P"K'X4_L$>([F;]L'1AJ_Q-^$OQ[U[Q=^P]X%M8/$OP
M5TT>'=)^$?AOP)XGL!;>#?'.CV.K>+;+5];\3ZKXGEN['Q%JFN0ZM:C0]0T^
MST:RTN1(D\=T/XG?LPO_ ,$U?CE\-/'^L^!/%_Q)UWXD_M-^'/ 'PRTN7P_X
M@^*FI?%G4OBWXSMOA\WA3POIN[7;;Q%9^))].U*UU&R,0T2W19[F[^QQX7^@
MKP?\*?AS\.8+V'X<^ ? _@!=1:.6_C\&^$M!\,0W\\*>7!+?Q:%I^GK?201M
M(+=KL3K"["0(Y1%7.T7X(?!_PWXBE\7>'?A1\,]"\533W-Q-XGT;P-X8TGQ%
M-/>O.]Y<R:WI^E6^IFZNGN9Y+FX^U&2YDFF:4EI6:L84IJG!.3NKW^?3_ASL
MEB(R<]-^75=>6_E;K^!^77QF9?AO\2_^"9/B3]J*9E^&OA3PEXP\,^-/$/BF
M0WO@?PM^T)J7P\\+VW@K6?'L\XATZTO+I;+QAIWA[Q#K-LVG:?K,TLOG:?=-
M%<S=?K?B?X<?$G_@IA^SSJ/P+U;2/%^O> _@]\8(?VA/%/P^N;34?#-CX,\2
MV^BK\./#WC?7=)>YT[4];E\3PW.K:'I%QJ-UJ5A;QWM[+!96^I6AN/U$UWPK
MHOBO1K[P[XJT30O$6@:G!+:ZEH.N:9::QHNHV[?*L5]INH036MQ 5&YK>2)E
MY6+S&6(/)C^!_AA\//AEILVC?#;P#X)^'VDW,[75SIO@KPOHGAC3I[PCY;R>
MQT73[&&XN8BJJDDF&*,V2"B"FZ4]/>>Z>Z_R(=6-GI?1JVEM;ZV[IG>+G')S
MZ'C)  &3@ 9.,G: !G@5^7__  5]TK2->_8RUG0-?BCN=!\1?%OX >&]=LY)
MWA^VZ+XA^,?A#2-3L5V')>_L[N:U1@ \8>29'5XEK]054*,#H69NI/+,6/7W
M)XZ#H. *Q=>\.:%XHLAIOB/1M(U_3A<6MZMAK>F66K6:WMA<1W=A>I::C#=6
MBW=E<1B>VN/LYG@G6*:&2-XE-:RCS+E[K?TMI\SGIRE3J*HM;.ZB]NVO]6/Y
MN?VT?V8OCWX:_9\\:K\>/&-GX@^ W[)_B?X0VW[)5W%XA,OB3QI/XM^-_P /
M-.L?%7Q12</(FN?"3P7?Q_"W03>1ROJ5Q+KGB#RMNH1W$GT+^W9\1_CAJ?[4
M</P5\._%6]^"/A?3_P!F5_B+\*?$D?QUM_@#I.M?%?\ X26]TW5=4\0ZK-HN
MI1^/=*\&VEEHDU]X#O[O3M*O]-U:XN;I72:%[G]OM9\-Z-XCTV;1?$>DZ5K^
MC7#VCSZ/K6GV>J:7.UC<QWEH\UE>P30RR6MW;VEW \H?9<VL,T2PNJE>>\:?
M"SX<_$>WTRT^(7@'P3XZMM$NA>Z+!XQ\*:#XG@T:\")']MTF#7=/U!+"]\J.
M.(W5N8YBJH2^(HT&*H2Y6E*SYD[^2;T]-?N.M8R4FG4I1:2EHE%:M+HDD[ZM
MOK=GYB_$B]^-GQ"^//[%_P %-9_: \:?#F/XA_LZ?$?Q5\7-1^!VO:+IW_"=
M>(/#5OX!"3:'KU]HNJG3;26ZUN\U.VUCPY'IVJPV+&+3;ZWL;B19/E[X?>/?
MCWH6C?L,?'3Q#^T_\6?'NK?%#]K_ ,3_ +-7B'PGXBU+0+/X::K\-++Q/\4O
M D277A+P[I&E1:_XQG'@72];3QIXAN]7UN'5);CR9+:$Q*/WU3PCX<6^TK5?
M^$>T%-5T.PFTO1=0BTFP6]T?2[CR?.TK2KPVIGT_39A;VPFM;,P0R_9XV>(X
M"K03X?>"DM]*LE\(>%(['0M6/B'0[./P]HXMM&\1//<W+Z]I4'V'R;#6!<WV
MHW0U.TCANWN-0NI&<-([.YT9MIJ=[)]=]K+\']Y"Q,>5I4>5N2Z+O+6^_5?^
M KNS^</XL>)1\-/BM_P4D^*_@[X^>/OAO\=_!7[1GPMD^$7PJ\*^,FAT7XM^
M(KKX>?#J*U\.>(/A*HEF^)-OXD-Y=Z9>RR0W+:1!91:A;&UEM)'N?H+]M7XG
M?'_Q!^TK-\)]$^*-Y\"X=$_9=T3XG_#C43\<$^ _AV\^*&I>(M8@\3ZQKU]<
M:+>6?Q-TSPT;'1;*]\"W\\>GV]A<WFH7UO>7E]:K9_M%/\&OA3=>,[?XBW/P
MS^'MQ\0+5XW@\=3^"_#<OC%'ACEB@D'B9]-.LB6".0K!(EY&\(+A6*L0;?C3
MX6?#GXCQZ7%\0_A]X$\>)H5VVH:&GC3PGH?BI=&U%@N;[31KEA>BTO6:.'==
MP"*<^1&Q9G 9%&E/V;CS6;:>^N[;VT+>*ASQ;I77*ULM'9+RT=F];O6WK^7_
M ,1]1^,/Q!_:E_8V^!FM?'CQGX"T?QS^R[XY^(WQ9/P.\26.@Q^._&?A'4?A
MXBS:/K<UE>76FZ+?ZEKFH7-OJNBPV.LW>EQI9+J,5K=W@'Z\6<9AMXXBYD\I
M0@D8J7D"@ 22%4C4R2?ZR0JBJ'8@ @;C@GPAX=&J:9KB>'] &M:)I]UH^C:L
MNE64>J:5H]Z]LUYIFFZBMNUQ86-R]I;37%G:^5;RRP1[D& Z](BE002"2S'Y
M054#.$ 4LV-J!0<$!F!?:"Q%;13C%)WD]%W[:ZG-.:EJH\OEIW;_ ":1\Y?M
M=ND?[*_[3CR%3%'^SW\:&F5F5 (O^%=>)-QWDADWA6!)^5@A&58 GY _8YT_
MXT>#?V#+'Q1XV^(7P^\0:>W[+WAO7?AN/ OP]O/!VJ>%HM-^&5W?M+XDU:X\
M5Z[9^*M3#1:7-:ZFNG:&EI<VUWB*8SLS?I]J.EV>K6=YIVI6EK?Z?J%M/97U
MC>P17-I>6-W%);WEI=VTT<D5S;7=M+);3P3(\3PS2AE;)5JMMH&E66DQ:!9Z
M9I=MH4-F--AT:&PMX]*BTQ(!:)IL>G(@M%LC9%K1K<1?9_)PJP ,PI2@W--.
MR2:ZEPJQ5)P</><XRNTME?3Y_ET/Q;L?&WQ<^+7PT_X)8^%$^/7Q(\ 3?'WP
MKXPNOBKXJ\!:WH^G^+/&<&C_  CL];:W75+_ $W4([.>74V\^WU'2K.+5-,+
MHNGR02;GKTCX\:1\3?$?[2_CGX6^'_VB?C7\.O!7PI_8@T#XF6&@>"_$6BVE
M[XE\:P>./B?I^G:_XJ\0ZSX>U77)W:/PMI U5[6]TQ]?%D+;69KO3I+JQG_4
MNV\$>%;-/#L5IX;T"UA\)02VWA:.WTC3H?\ A&+>XM5L;BW\.O%:(VCQ360^
MR3"P\@RVZ)"VU!\MV;PSH5SJ%WJ]UHVC3ZO?:4N@WNJOI=DVH7>AQSW%Q%H]
MS=S0S7$^E137=U,FFRRO9B>ZNIA$KW$E3*G*2LIV\]?\QJK%23Y%:SZ+JTUT
M[:=3\1_V8?'_ ,;)?B]^P!X[\7?M#_$OXB7/[6OP*^)?B+XG^$/$EUH<'P\D
MO_#OAKPSXD\/7?@GP;H6E:7I/A.[T![Z[M)M0T4M?:Q;7LTFO2WLVUUZ+]DG
MXKZ_I7[</Q*^%7Q0^.WB?XY^,?B+;_$?X@?#;6OA]\;-,\;_  +TGX::+XDL
MK"R\*:[\&;#;#\'_ !KX=79IBS!+JU\0WL>ORIK?G 6@_8>S\">#]./AYM/\
M*^&[)O"-E/IWA,VVAZ5"WA>PN;>.TNK#P])'9))HUG=6L,$%Q!8&"*:*&..6
M.6-0M8?A+X/?"SP%K&K>(O!'PV^'W@_7]>9VUK6O"_@SP[X?U;6#(ZS.^JZC
MI.G6EU?R27*FY<SNT9F=Y6B:8M*V:H333]HW9K37_,OV\+2_=K6+2T6_1_H>
MCH<@^N>1DY!(#8(.67@@A3T!&,+@44(I4$$YY&/IM4'L",L&8[F=B23OP0JE
M=1QW_NM?)?YCZ***"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
B*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001887673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">WEARABLE DEVICES LTD.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Oct. 26, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Ordinary Shares<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">3,322,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">2.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 8,703,640.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 1,201.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The ordinary shares, no par value per share (&#8220;Ordinary Shares&#8221;), of Wearable Devices Ltd. (the &#8220;Company&#8221;) being registered hereunder are being registered for sale by the selling shareholder named in the prospectus to which this Registration Statement on Form F-3 relates. In accordance with Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the Ordinary Shares registered hereby also include an indeterminate number of additional Ordinary Shares as may from time to time become issuable as a result of share splits, share dividends, recapitalizations or other similar transactions. The amount registered represents 3,322,000 Ordinary Shares underlying ordinary warrants which were issued by the Company to the selling shareholder pursuant to an Inducement Offer Letter Agreement, dated as of August 6, 2025, by and between the Company and the selling shareholder. The proposed maximum offering price per share is estimated solely for purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act and is based on the average of the high ($2.73) and low ($2.50) sales prices of the Company&#8217;s Ordinary Shares as reported on the Nasdaq Capital Market on October 22, 2025. The Company will not receive any proceeds from the sale of Ordinary Shares by the selling shareholder.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 26, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 8,703,640.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">1,201.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 1,201.97<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea026255801ex-fee_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea026255801ex-fee_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea026255801ex-fee_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ea026255801ex-fee_wearable.htm">ea026255801ex-fee_wearable.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="21">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea026255801ex-fee_wearable.htm": {
   "dts": {
    "inline": {
     "local": [
      "ea026255801ex-fee_wearable.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 21,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026255801ex-fee_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026255801ex-fee_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026255801ex-fee_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026255801ex-fee_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026255801ex-fee_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026255801ex-fee_wearable.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001213900-25-102562-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-102562-xbrl.zip
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M/;)EE4G,+)(:'X^3FJ,O<ZR]4BE'J"3 $8"Q*55,@X_UB" S2IY5$ @/624
M&1VWSSBA/OS). !XL$QQ MD%WTL%%C# 4$2L]6>0 E\>'9%.%'A$022A@O3O
M-G<"^"6D[&MKH@# @NR[6JK8'V3H"@7N$C\Q\8AO4#(8B#BXH;YL^*:5*\'%
M2(!GIT0*3[C@6_H+ACB+@7;1"VE\ 38A)^10( DFD20[HGPB@E:^.T(/R/QX
M0"-\#THFQAX -BT*X$R<)G%"+>\"'PK[$0@/' $,:+?IL[X3.XB..7+&%;!)
M:MV(Z^$<8:!WAJH"#=7Z78A=4L[AIU?;.:2+[R&UN1IP[D_Q@.,+F(@U$Z97
MKEYR^YE&,\S@;>LX0L&I.60,3S,"90R'^AKC!61!#,B8D]Y+PW(U5CO,X%,T
M&1*0)*:T$#O\]@Y^4+;0YU$:8 ._+F$82IH&9%;:Y2F1'J1%\N%GN[!3^JCA
MW6"@G[?-CSJT92R83!=,I QK9U_.<^-XOQV3;%')Z%^D'OLA^4RC!ZY#^]Q1
M 08&N),V3:SBU!8#X;J0_M -'2X>,:Y&J'^'<R:3.$%38?X!YF8969R2YKQ6
MEVW=D/ZSS1OV<?RB!?=S_-BE^A]02P$"% ,4    "  D@%M;ZRUJ&<P+  #R
M-P  '@              @ $     96$P,C8R-34X,#%E>"UF965?=V5A<F%B
<;&4N:'1M4$L%!@     !  $ 3     @,      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ea026255801ex-fee_wearable_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-26</startDate>
            <endDate>2025-10-26</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2025-10-26</startDate>
            <endDate>2025-10-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">F-3</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001887673</dei:EntityCentralIndexKey>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_004" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_005">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_006">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_007">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_008">WEARABLE DEVICES LTD.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_009">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_010">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_011">Ordinary Shares</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_1" id="fee_012">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_013"
      unitRef="shares">3322000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_014"
      unitRef="USD">2.62</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="USD">8703640.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_017"
      unitRef="USD">1201.97</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_018"
      unitRef="USD">8703640.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_019"
      unitRef="USD">1201.97</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_020"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_021"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_022"
      unitRef="USD">1201.97</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="fee_023">The ordinary shares, no par value per share (&#x201c;Ordinary Shares&#x201d;), of Wearable Devices Ltd. (the &#x201c;Company&#x201d;) being registered hereunder are being registered for sale by the selling shareholder named in the prospectus to which this Registration Statement on Form F-3 relates. In accordance with Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), the Ordinary Shares registered hereby also include an indeterminate number of additional Ordinary Shares as may from time to time become issuable as a result of share splits, share dividends, recapitalizations or other similar transactions. The amount registered represents 3,322,000 Ordinary Shares underlying ordinary warrants which were issued by the Company to the selling shareholder pursuant to an Inducement Offer Letter Agreement, dated as of August 6, 2025, by and between the Company and the selling shareholder. The proposed maximum offering price per share is estimated solely for purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act and is based on the average of the high ($2.73) and low ($2.50) sales prices of the Company&#x2019;s Ordinary Shares as reported on the Nasdaq Capital Market on October 22, 2025. The Company will not receive any proceeds from the sale of Ordinary Shares by the selling shareholder.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
